{"_id":"IWv0YhZPqcbDXvo33i8YDKHf1qwCyZIJRuDyxUYmcwO5HCb3r4Tdyt","lastupdate":"2024-06-03T00:00:00.000Z","update_date":"2024-06-03T00:00:00.000Z","lastModified":"May 15, 2025","active":1,"confidence_score":94,"confidence_score_reason":"markets, not claimed","urlname":"evinature","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$vuM3IGluLfm2P2BtUqAnsuHR68exJCikQC1iAvxgv4quP77hhIqhmZ","name":"Evinature","oneliner":"Clinically proven, evidence-based nutraceuticals for gut health tailored to IBD, IBS, diverticulitis","registrar":"516384070","website":"https://evinature.com/","careerspage":"","founded_month":4,"founded_year":2021,"formernames":[],"sociallinks":{"twitter":"https://twitter.com/Evinature_","youtube":"https://www.youtube.com/@Evinature","facebook":"https://www.facebook.com/evinature","linkedin":"https://www.linkedin.com/company/79820201","instagram":"https://www.instagram.com/evinature"},"social":["https://www.linkedin.com/company/79820201","https://twitter.com/Evinature_","https://www.youtube.com/@Evinature","https://www.instagram.com/evinature","https://www.tiktok.com/@evinature","https://www.facebook.com/evinature"],"flattenedsociallinks":"https://www.linkedin.com/company/79820201|https://twitter.com/Evinature_|https://www.youtube.com/@Evinature|https://www.instagram.com/evinature|https://www.tiktok.com/@evinature|https://www.facebook.com/evinature","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"11-50","employees_exact":17,"patent":1,"raised":6500000,"stage":"Seed","public_stage":"Seed","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["avenature","Evanature","avinature","curqd","ivenature","ivanature"],"about":"Evinature was founded on the nexus of two medical philosophies. By bridging the gap between modern and traditional medicine, we’re able to provide more patients with safe and natural remedies that are embraced by the medical community.\n\nWe believe it’s time for healthcare to prioritize patient global accessibility to accurate medical assessments and affordable treatments. No patents, no trends, no misinformation. We simply develop, test, prove, then give back to the community.\n\nTailored Protocols:\nNo two bodies are the same, which is why we provide evidence-based protocols that address each patient’s condition and state of severity so we can precisely target your individual needs and improve long-term results.\n\nGuided Care:\nRegular online follow-ups enable precise adjustments to your protocol so we can address your changing needs throughout treatment. And to ease the way, we also provide complementary clinic support to guide you through the entire process.\n\nLabs:\nWe’re constantly refining our products through ongoing research and collaborations with over 20 leading medical centers in the U.S, enabling the further development of effective neutraceuticals that are accessible to patients worldwide.\n\nEvidence:\nEvinature prioritizes evidence above the trends. We are caregivers by profession, and therefore emphasize product quality and scientific integrity above all else, exclusively distributing products that have passed the golden standard of clinical trials.\n\nBy the Patient for the Patient:\nPatients are the greatest untapped resource in healthcare, which is why we’ve developed a research database founded on their invaluable experience. At Evinature, each patient contributes to the community simply by taking the assessment. This allows us to constantly expand our research and keep the community updated with vital news and information.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+1 (612) 261-0298","country":null,"address":{"israeli":[{"id":"wB9AMYmba1Y3QKiFNBxrNeZWPlh9xRZ2MEwOuhTC8v6ML1DbbvnnYf","city":"Binyamina-Giv'at Ada","type":null,"address":"HaMelacha St 3, Binyamina-Giv'at Ada, Israel","placeid":null,"notactive":null,"openeddate":null,"registrarid":null,"firstrdcenter":null,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":null,"news":[{"id":"2Hb0VmYOwVyGg4PMiKovKgY5dXpeUtxY81dTe5tzyyu9gh80yqae9r","date":"May 12, 2025","link":"https://evinature.com/blog/news/evinature-digestive-disease-week-2025/","source":"evinature.com","visible":1,"analysis":{"tags":"innovation","round":null,"company":"Evinature","layoffs":null,"summary":"At the Digestive Disease Week (DDW) 2025 conference, Evinature showcased its CurQD® Protocol, a clinically validated nutraceutical for treating IBD, including Ulcerative Colitis and Crohn’s Disease. The protocol was highlighted for its cost-effectiveness compared to FDA-approved therapies and does not require FDA approval to reach patients. Evinatures co-founders engaged with medical institutions and researchers, reinforcing CurQD®s reputation as a viable treatment option. The conference facilitated discussions with pharma representatives and gastroenterology leaders, emphasizing CurQD®s potential to make gut healthcare more affordable. Evinature aims to expand CurQD®s reach through clinical partnerships and global recognition.","partners":["Rabin Medical Center","University of Chicago"],"customers":null,"eventType":null,"investors":null,"confidence":9,"key_topics":["CurQD® Protocol","IBD treatment","cost-effectiveness","clinical study","partnerships"],"date_of_event":"May 3-6, 2025","product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Product Stage","Partners"],"acquisition_amount":null,"FDA approved/pending approval":"not required","AI technology developing/using":"not mentioned","structuredIssuesShow":"#Product Stage  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"JVHs3p6xnzxncTesIqTiSRjMPwqaf0TWJX3s4zWdEvUBjbiA0OEx0m","news_summary":"New CurQD Research Makes Waves at USA's Largest GI Conference | Evinature","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"RWm4qF5842uN7b7HHoAFpooQurB71O6yAshs5xHfEA7VXdHeM2rIE3","date":"Feb 19, 2025","link":"https://evinature.com/blog/news/curqd-highlighted-at-crohns-colitis-congress-2025/","source":"evinature.com","visible":1,"analysis":{"date":"Wed Feb 19 2025","status":429,"message":"You exceeded your current quota, please check your plan and billing details. For more information on this error, read the docs: https://platform.openai.com/docs/guides/error-codes/api-errors.","entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"KGoYX3f29DeihT8ksjb4rxDziWXFV6hVIvgY6nJTMh9AVZCTKShMPF","news_summary":"CurQD Protocol by Evinature Highlighted at Crohn’s & Colitis Congress 2025","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"uvGA4hXCvRb6XTBGZ9osCB90nJhlftHVlb86tHmQMcFfZQVyY32lXl","date":"Feb 9, 2025","link":"https://evinature.com/blog/news/tals-journey-overcoming-16-years-of-ulcerative-colitis-with-natural-treatment/","source":"evinature.com","visible":1,"analysis":{"tags":"natural treatment","round":null,"company":"Evinature","layoffs":null,"summary":"The article narrates the story of Tal, who battled ulcerative colitis for nearly two decades. Despite trying various medications and biological treatments, he found no lasting relief until he discovered the CurQD® Protocol from Evinature. This natural treatment transformed his life, leading to full remission within weeks. Tals story highlights the potential of natural solutions in managing chronic conditions like ulcerative colitis. The CurQD® Protocol allowed him to regain his health and return to his active lifestyle, serving as an inspiration for others seeking alternative treatments.","partners":null,"customers":null,"eventType":null,"investors":null,"confidence":9,"key_topics":["ulcerative colitis","natural treatment","clinical trial","remission","CurQD Protocol"],"date_of_event":null,"product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Product Stage"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"not using","structuredIssuesShow":"#Product Stage","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"qvNFGcNLlTF1dL0PBY2FPVOxSVXqpetVYjFfp9otc1qDvqXW9urdCn","news_summary":"Tal’s Journey: Overcoming 16 Years of IBD - evinature","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"Rrjy7R1q7pjc9iquUO8Q9ntoZWM6iHWQ7tlPuLLO8aN9IRL1kdiLPQ","date":"Feb 6, 2025","link":"https://evinature.com/blog/news/evinature-presents-groundbreaking-curqd-research-at-gedii-conference-in-portugal/","source":"evinature.com","visible":1,"analysis":{"tags":"IBD treatment","round":null,"company":"Evinature","layoffs":null,"summary":"At the GEDII annual IBD conference, Evinatures co-founder, Dr. Prof. Shomron Ben Horin, presented findings from recent placebo-controlled trials on CurQD®, a natural supplement for gastrointestinal conditions. The conference, attended by leading gastroenterologists and researchers, highlighted CurQD®s potential to complement conventional therapies. Dr. Ben Horin emphasized the importance of global collaboration in advancing IBD treatment and noted the growing interest in integrating natural, evidence-based solutions into clinical practice. Evinature remains committed to pioneering natural, science-backed solutions for gastrointestinal health, with CurQD® at the forefront of innovation.","partners":null,"customers":null,"eventType":null,"investors":null,"confidence":9,"key_topics":["IBD conference","CurQD® trials","natural supplements","gastroenterologists","international collaboration"],"date_of_event":"January 2025","product_stage":"clinical trial","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":[],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":null,"entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"wRhxYvWNXQqWt9yIzdfapNb1SkQaNfOkLpZsZT3aL9WO0cVlAtGcxZ","news_summary":"Evinature Co-Founder Dr. Prof. Shomron Ben Horin, MD Presents Groundbreaking CurQD® Research at GEDII Conference in Portugal","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"Y9Oh3c16PLch87jHwsRn1JuTsQ480lmwv2MdOdihz0XEK5LGQlsGvx","date":"Jan 29, 2025","link":"https://evinature.com/blog/news/lucys-journey-to-remission-how-curqd-transformed-her-life/","source":"evinature.com","visible":1,"analysis":{"tags":"remission, healing","round":null,"company":"Evinature","layoffs":null,"summary":"The article highlights Lucys journey to remission from Crohns and ulcerative colitis using Evinatures CurQD® Protocol. After years of struggling with her condition and trying various treatments, Lucy found success with CurQD®, which significantly improved her quality of life. She praises the product for its effectiveness and affordability, and appreciates the support and community provided by Evinature. Lucys story underscores the transformative potential of CurQD® and offers hope to others seeking natural healing paths. Evinatures personalized approach and community support are also emphasized as key factors in her successful remission.","partners":null,"customers":null,"eventType":null,"investors":null,"confidence":9,"key_topics":["remission","healing","Crohns","colitis","CurQD"],"date_of_event":null,"product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":[],"acquisition_amount":null,"FDA approved/pending approval":null,"AI technology developing/using":null,"entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"3DpgqSyxn3vKyPQuIrjxGy2xmNzKo8imJPIgw4OkuY18XHpfa0kJQX","news_summary":"Lucy’s Journey to Remission: How CurQD Transformed Her Life - evinature","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"BzdWdeXB0wJw60nSCX80tnMjvPeZiTQwrlXUoyOoYaEuigeSIlMbZI","date":"Jan 22, 2025","link":"https://evinature.com/blog/news/evinature-co-founder-shares-insights-in-live-interview-with-leading-ibd-advocate/","source":"evinature.com","visible":1,"analysis":{"tags":"gut health","round":null,"company":"Evinature","layoffs":null,"summary":"Evinatures co-founder, Nir Salomon, participated in an Instagram Live interview with Liam Robertson, discussing the companys origins, the science behind their CurQD® Protocol, and future plans for gut health solutions. The conversation covered the clinical trials of CurQD®, potential insurance coverage in the U.S. and UK, and other products like DivertX and Exhale. Evinature aims to make clinically-proven, natural gut health solutions accessible, reshaping the standard of care for IBD and related conditions. The company is focused on ongoing research and innovation to improve gut health worldwide.","partners":null,"customers":null,"eventType":null,"investors":null,"confidence":9,"key_topics":["CurQD Protocol","clinical trials","insurance coverage","gut-brain connection","future roadmap"],"date_of_event":null,"product_stage":"clinical trial","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Product Stage","Customers"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"not mentioned","structuredIssuesShow":"#Product Stage  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"LoebdR6pb73VuQAa7cVhkinXhtEWbnCJhysNh97qjsRuf5cERjY7HQ","news_summary":"Evinature Co-Founder Nir Salomon, ChB, Shares Insights in Live Interview with Leading IBD Advocate","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"3bmA1kWanTvmRZ6H7VEDtvyF2JycgZsC02KqTNARMkkaFkjabcPGwY","date":"Dec 24, 2024","link":"https://evinature.com/blog/gut-health/curqd-takes-center-stage-at-aibd-conference/","source":"evinature.com","visible":1,"analysis":{"date":"Wed Feb 19 2025","status":429,"message":"You exceeded your current quota, please check your plan and billing details. For more information on this error, read the docs: https://platform.openai.com/docs/guides/error-codes/api-errors.","entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"6ZvfDK6mdgVsSsQhxgvW5zC1GBOYE1pnVOcHfZoeFDZY08bdkhRu5t","news_summary":"Evinature Takes Center Stage at AIBD Conference","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"icfGcvbm0ZR7mV2ZIfxz3jBXHHiWOQzKF1E9pXx9AtOqfrLj4NC8Dt","date":"Nov 26, 2024","link":"https://evinature.com/blog/gut-health/curqd-found-to-ease-life-altering-ibd-symptom/","source":"evinature.com","visible":1,"analysis":{"tags":"healthcare","company":"Evinature","layoffs":null,"summary":"Evinature has published promising research on their nutraceutical product, CurQD®, which shows significant improvement in managing bowel urgency symptoms in patients with IBS and IBD. The study, published in the Journal of Crohn’s and Colitis, involved 41 participants, with 70% experiencing improvement by weeks 4 and 8. The product is also effective in pediatric cases, offering a solution for children who struggle with bowel urgency. Evinature is committed to enhancing the quality of life for its customers through personalized treatment and clinical support, aiming to reduce the frequency of symptoms and improve overall GI tract health.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["IBS","IBD","CurQD","research","pediatrics"],"date_of_event":"2024","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"v3LWwgkoigIEbJq7VDJInn8CWfrZ9USj11syRCv2ttqjI8mWs7Kthu","news_summary":"CurQD by Evinature Found to Ease Life-Altering IBD Symptom","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"vFC5wua3Ii2N7V0hwiz4pX1EOb4tkkLh9pK5v6j9N3aNKkaqPPjhEx","date":"Nov 21, 2024","link":"https://evinature.com/blog/gut-health/curqd-successful-reducing-symptoms-ibd-in-pediatric-trial/","source":"evinature.com","visible":1,"analysis":{"tags":"pediatric treatment","company":"Evinature","layoffs":null,"summary":"Evinature has developed CurQD®, a curcumin-Qing Dai formula, which has shown promising results in reducing symptoms of mild and moderate Ulcerative Colitis (UC) and Inflammatory Bowel Disease (IBD) in pediatric patients. In a multi-center study involving 30 pediatric UC patients, 72% responded positively to CurQD®, with significant reductions in symptom severity and colon inflammation. The study highlights the potential of CurQD® as a supplemental treatment that can improve the quality of life for young patients by reducing the side effects of both the illnesses and medications. The trials success marks a significant advancement in pediatric UC treatment, offering new hope for affected children to lead more normal lives.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["CurQD®","pediatric UC","clinical trial","symptom reduction","quality of life"],"date_of_event":"2024","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":[],"acquisition_amount":null,"entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"2fCP5dcju3UkGOTGRRnjggM5dLCRrwRF3loxPgpMxz0l7aMG7ird0R","news_summary":"Evinature's CurQD Successful in Pediatric Trial","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"QeSw2C6mcZ8u5N3R7cAMzZN81WMTVSIXgPsoY3YOo98yJiXt0OXH04","date":"Sep 27, 2024","link":"https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2024.1342656/full","source":"www.frontiersin.org","visible":1,"analysis":{"tags":"pediatric UC treatment","company":"Evinature","layoffs":null,"summary":"The article discusses a study on the efficacy and safety of a combination treatment using curcumin and Qing Dai (CurQD) for pediatric patients with ulcerative colitis (UC) or inflammatory bowel disease unclassified (IBD-U) who did not respond to conventional treatments. Conducted across four pediatric gastroenterology units, the study involved 30 children and demonstrated a significant clinical response in 70% of the patients after 16 weeks of treatment. The study highlights the potential of CurQD as a safe and effective management option for pediatric UC, with minimal adverse effects reported. The treatment was produced by Evinature, a company based in Israel. The study emphasizes the need for larger prospective studies to further evaluate the clinical and endoscopic effects of CurQD in children.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["ulcerative colitis","pediatric treatment","CurQD efficacy","safety profile","traditional medicine"],"date_of_event":"2017-2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":[],"acquisition_amount":null,"entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"XwDsfoTlg6OcxFQ6rWqIjPPSdMSmdFpmfOWjpU1L8TkxDe1cpD9LdR","news_summary":"The efficacy of CurQD in children with active ulcerative colitis: a multicenter retrospective cohort study","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"Kx0s21e6r1TX2Pk0AUh8aYi7DY4GCY9WSiqoCujddDOtRJaTXkQMoi","date":"Aug 28, 2024","link":"https://thesanfranciscotribune.com/6-companies-making-waves-in-modern-innovation/","source":"thesanfranciscotribune.com","visible":1,"analysis":{"tags":"innovation","company":"Substrata","layoffs":null,"summary":"The article highlights six companies leading innovation across various industries. Substrata is transforming business interactions through its deep learning-driven social signal intelligence platform, enhancing decision-making and strategic planning. Evinature is revolutionizing the treatment of inflammatory bowel diseases with its CurQD® Protocol, developed in collaboration with Sheba Medical Center. ANYBiotics is advancing synthetic biology, creating sustainable biomaterials and chemicals. Harvestly is promoting sustainable agriculture through technology integration, improving crop yields and supporting small-scale farmers. Pet Tech is enhancing pet care with AI and smart devices, improving pet health and owner convenience. Suno is reshaping music creation with AI technology, making it accessible to a broader audience. Each company is setting new standards in their respective fields, driving positive change and innovation.","partners":["Sheba Medical Center"],"customers":null,"investors":null,"confidence":9,"key_topics":["innovation","technology","healthcare","agriculture","music"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":[],"acquisition_amount":null,"entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"EGyC6Bsjd1U634pHpkcMaPY5NqWyLei6UhPAQ2unBOLxRAtSyzeSrm","news_summary":"6 Companies Making Waves in Modern Innovation","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"qMsz8xGsLCot3IUWMF86ZZuEqyH5dS9p0zsIMFWvX1cTEEqK05vA36","date":"Aug 27, 2024","link":"https://worldfinancialreview.com/these-are-the-5-next-gen-startups-disrupting-their-industries/","source":"worldfinancialreview.com","visible":1,"analysis":{"tags":"innovation","company":"Evinature","layoffs":null,"summary":"The article highlights five next-gen startups that are making significant strides in their respective industries by leveraging cutting-edge technology and innovative approaches. Evinature is advancing natural healthcare with its personalized treatments for gastrointestinal disorders. Lunar.dev is transforming API consumption management with enhanced security and cost-saving features. Fishway is pioneering sustainable seafood production through cell cultivation. Brightwheel is modernizing childcare management with its comprehensive SaaS platform. HGenium is innovating green hydrogen production with its sustainable thermochemical water-splitting technology. These startups are setting new standards and redefining industry benchmarks, showcasing the potential for transformative change.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["healthcare","API","aquaculture","childcare","hydrogen"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":[],"acquisition_amount":null,"entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"1oRw71Y8isFloBwgTClIwx8AhDOmAkrcPIGoqrscSMFqNok3aIjtSc","news_summary":"These are the 5 Next-Gen Startups Disrupting Their Industries - The World Financial Review","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"Whj6D060LbuOwjnid6RaZsh2aIFJKBnqEctckUq9Q7Bnty809cucXr","date":"Jul 29, 2024","link":"https://ritzherald.com/6-companies-that-are-redefining-their-markets/","source":"ritzherald.com","visible":1,"analysis":{"tags":"Innovation, Technology, AI, Automation, Education, Healthcare, Agriculture, Cybersecurity, Revenue Intelligence","company":["Vendict","Gyaan","Evinature","Pivot Bio","Rockwell Automation","CENTURY"],"layoffs":"Not mentioned","summary":"The article discusses six companies that are redefining their respective markets through innovative products and services. Vendict is revolutionizing the cybersecurity and risk management sector with its AI-driven solutions. Gyaan is transforming the revenue intelligence market with a platform that provides actionable insights. Evinature is redefining natural health solutions by integrating scientific research with evidence-based herbal medicine. Pivot Bio is revolutionizing agriculture with microbial solutions that replace traditional fertilizers. Rockwell Automation is catering to the demand for large-scale industrial automation. CENTURY is enhancing learning in high school and college subjects by leveraging neuroscience.","partners":"Not mentioned","customers":"Not mentioned","investors":"Not mentioned","confidence":8,"key_topics":["AI-driven solutions","Revenue Intelligence","Natural Health Solutions","Sustainable Crop Fertilizer","AI Industrial Automation","Student Learning Program Matching"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Customers","Partners","Investment","Acquisition","Public Trading","Management Changes","Layoffs","Expand"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Customers  #Partners  #Investment  #Acquisition  #Public Trading  #Management Changes  #Layoffs  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"dQRHUJ9EV8UWfrn04k2y91yrXRi0OziGf6xvwFpQkm5kB2yU9euxPp","news_summary":"6 Companies That Are Redefining Their Markets","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"62fs75x4QHuYPzQ9XB6B5l7j35m1vCH1nzGz2ocn7D5QhWFq6otKUb","date":"Jul 17, 2024","link":"https://finder.startupnationcentral.org/reports/snc-h1-2024-report","source":"finder.startupnationcentral.org","visible":1,"analysis":{"tags":"N/A","company":"N/A","layoffs":"N/A","summary":"The text appears to be a mix of prompts, instructions, and placeholders from a website interface, possibly related to a tech startup database or platform. It does not provide any specific information about a company, event, or issue.","partners":"N/A","customers":"N/A","investors":"N/A","confidence":10,"key_topics":"N/A","date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"N/A","investment_amount":"N/A","structured_issues":"N/A","acquisition_amount":"N/A","structuredIssuesShow":"#N/A","entityGrowthIconPath":"none;"},"sentiment":"N/A","analysisId":"C8SkoYqXu23RkpNO5pl7UPJa89urTCdPCJlFfgMq3Xxp4k5UxQnFfF","news_summary":"Evinature listed top among most-watched Health Tech companies in Startup Nation's H1 2024 Israeli Tech Report","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"DiI169tGLIRB0Hp8u3DL0gR7R9gjCvxodhnVIYtVsZKNTunIHkFx17","date":"Jun 18, 2024","link":"https://www.healthcarebusinesstoday.com/meet-the-research-team-that-broke-the-therapeutic-ceiling-in-ibd/","source":"www.healthcarebusinesstoday.com","visible":1,"analysis":{"tags":"Healthcare, Herbal Medicine","company":"Evinature","layoffs":"Not mentioned","summary":"Evinature, a healthcare startup, is pioneering the integration of herbal medicine into standard clinical care. The company is dedicated to providing evidence-based, natural remedies to patients worldwide. Evinatures co-founders recently attended the Digestive Disease Week Conference where they presented their latest research on DivertX, a natural treatment for Post-Diverticulitis Syndrome (PDS). The companys research efforts, in collaboration with Sheba Medical Center, have led to the establishment of the first disease index to address unmet needs in gastroenterology. Evinatures approach is grounded in evidence and patient-centric values, promoting a holistic model of care.","partners":"Sheba Medical Center","customers":"Patients worldwide","investors":"Not mentioned","confidence":9,"key_topics":["Herbal Medicine","Healthcare Startup","Clinical Care","Medical Research","Patient Care"],"date_of_event":"May 18-21, 2024","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Customers","Partners"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"3rjAW2Ncy6oqQ8PBJQZ9u7BPQRdKX1AzhMXPeV5cNXowgmNvwjnD2h","news_summary":"Meet The Research Team That Broke The Therapeutic Ceiling In IBD  - Healthcare Business Today","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"rqQZslbPhRlSv7VBjZVRpv40CkgfVBpf6Id8xvIe6bCdtlMD8jdLX8","date":"May 9, 2024","link":"https://www.biopharmadive.com/press-release/20240509-breaking-boundaries-in-ibd-evinatures-curqd-trial-spotlighted-at-the-ccf/","source":"www.biopharmadive.com","visible":1,"analysis":{"tags":"Research, Healthcare","company":"Evinature","layoffs":"Not mentioned","summary":"Evinature, a healthcare startup, was invited to the 6th IBD Innovate Conference hosted by the Crohn’s & Colitis Foundation. Nir Salomon, Co-founder and Head of R&D at Evinature, presented CurQD®, a first-in-class nutraceutical for Inflammatory Bowel Disease (IBD) with high remission rates in patients failing pharmaceutical treatment. The product is available through Evinature’s platform, which facilitates direct-to-patient treatments using data-driven, tailored protocols. The conference served as a platform for knowledge exchange and collaboration among startups, innovators, researchers, and industry stakeholders.","partners":"Crohn’s & Colitis Foundation","customers":"Patients with Inflammatory Bowel Disease","investors":"Not mentioned","confidence":8,"key_topics":["IBD Innovate Conference","Crohn’s & Colitis Foundation","CurQD®","IBD treatment","Evinature platform"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Partners","Customers"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"TQg3TWyNxn0GpFXyRaz00jYLFEKPz7AlWQrIxbleooPhIS2Z7OOqM6","news_summary":"Breaking Boundaries in IBD: Evinature's CurQD® Trial Spotlighted at the CCF’s IBD Innovate Conference 2024 | BioPharma Dive","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"IUTvR4TruoSYpb7yEFraWahRTwBnGgNHM2kjKcbGoA14QEElKAZ9LO","date":"Apr 18, 2024","link":"https://ritzherald.com/meet-the-frontmen-of-evinature-the-startup-thats-revolutionizing-ibd-care/","source":"ritzherald.com","visible":1,"analysis":{"tags":"Healthcare, IBD Treatment","company":"Evinature","layoffs":"N/A","summary":"Evinature, a healthcare startup, is pioneering new technologies and therapies for the treatment of Inflammatory Bowel Disease (IBD). The companys founders, Professor Shomron Ben-Horin, M.D., Nir Salomon, and Apan Amos Damri, have developed the CurQD® Protocol, a set of natural, clinically proven regimens tailored specifically to each individual to address each stage of IBD. The protocol has been integrated into top medical centers and offers a safe and effective alternative to traditional pharmaceuticals. Evinatures platform also provides integrative strategies, guided care from a team of experts, research updates, and essential information to the community.","partners":"Sheba Medical Center","customers":"IBD Patients","investors":"N/A","confidence":9,"key_topics":"Inflammatory Bowel Disease, Nutraceutical Therapies, Personalized Treatment, CurQD® Protocol, Healthcare Startups","date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Customers, Expand","acquisition_amount":"N/A","structuredIssuesShow":"#Customers, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"AgeXhWdo6h9p9k3jTX1IItcnO1s41IMZb2ndGhPqFaeK6ZknrS8Wsf","news_summary":"Meet the Frontmen of Evinature, the Startup That’s Revolutionizing IBD Care | The Ritz Herald","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"S4t452eRkOe8uHRrgFdDe5ONkraTXWAcdNtOfWFtOPABgbfHEXaC8d","date":"Apr 8, 2024","link":"https://www.digitaljournal.com/business/healthcare-startup-evinature-is-now-integrated-across-35-us-medical-centres-to-further-streamline-ibd-treatment-accessibility/article","source":"www.digitaljournal.com","visible":1,"analysis":{"tags":"Healthcare, Research","company":"Evinature","layoffs":"NA","summary":"Evinature, a healthcare startup, is leading research in nutraceutical therapies for Inflammatory Bowel Disease (IBD) patients. The company has integrated CurQD as an adjunct therapy into standard care through evidence and clinical trials. This has led to collaborations with doctors in the US who have seen a demand from patients. In the past year, CurQD has been integrated into over 35 medical centres across the US as part of Evinatures aim to improve IBD treatment and patient outcomes. The company has also launched the CurQD Network, a platform that allows patients to access the CurQD Protocol through their healthcare providers.","partners":"US medical centres","customers":"IBD patients","investors":"NA","confidence":8,"key_topics":["IBD treatment","CurQD protocol","Nutraceutical therapies","Healthcare collaboration","Patient outcomes"],"date_of_event":"NA","valuation_amount":"NA","impact_on_company":"growth-positive","investment_amount":"NA","structured_issues":["Customers","Partners"],"acquisition_amount":"NA","structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"uWJ8vlTa0pqfKBjIxJeMGL8RNKtsmEn89sGKMMfikK2c1RJfuqXKHx","news_summary":"Healthcare startup Evinature is now integrated across 35 US medical centres to further streamline IBD treatment accessibility - Digital Journal","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"m1cjuVEzLlednaTb7mlHcpgH8fThZut9964cQe8Y9ZWZZE23rEZVbv","date":"Feb 19, 2024","link":"https://womensjournal.com/evinature-pioneering-integrative-therapies-for-ibd-with-the-curqd-protocol/","source":"womensjournal.com","visible":1,"analysis":{"tags":"Healthcare, IBD Treatment","company":"Evinature","layoffs":"NA","summary":"Evinature, a healthcare clinic, is leading the way in research for integrative therapies for Inflammatory Bowel Disease (IBD). The company has developed the CurQD® Protocol, a set of natural, clinically proven regimens that are highly individualized to address each stage of IBD. The protocol is now integrated into standard clinical practice in leading medical centers in Israel. Evinatures approach emphasizes the uniqueness of each patient and the dynamic nature of their conditions. The company also provides ongoing patient support, including regular follow-ups and free educational content.","partners":"NA","customers":"IBD Patients","investors":"NA","confidence":9,"key_topics":["Personalized IBD Treatments","CurQD® Protocol","Patient Care","Holistic Approach","Patient Support"],"date_of_event":"NA","valuation_amount":"NA","impact_on_company":"growth-positive","investment_amount":"NA","structured_issues":"Customers, Expand","acquisition_amount":"NA","structuredIssuesShow":"#Customers, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Je0hqjYiuMrjhx8MzejYsMW5M4plhTgt66qmfxBvJQLAcwHSN8C0zF","news_summary":"Evinature: Pioneering Integrative Therapies for IBD with the CurQD® Protocol - Women's Journal","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"GLXoJ0WKo7KayfKz8KFKiRp6Nk1EgLU3C4PNOfIc5i3N8chylJWN7C","date":"Feb 12, 2024","link":"https://www.europeanbusinessreview.com/harvard-medical-professor-ashwin-ananthakrishnan-commends-evinatures-curqd-trial-in-cgh-editorial/","source":"www.europeanbusinessreview.com","visible":1,"analysis":{"tags":"Healthcare, IBD Treatment","company":"Evinature","layoffs":"Not mentioned","summary":"Evinature, a company focusing on integrative therapies for Inflammatory Bowel Disease (IBD), has been recognized for its CurQD® Protocol. The protocol, which combines the therapeutic properties of curcumin and Qing Dai, has been published in the Clinical Gastroenterology and Hepatology journal, sparking interest within the medical community. The companys approach to IBD treatment emphasizes the need for a holistic approach, addressing concerns about the long-term safety and potential side effects of conventional treatments. The endorsement from respected authorities like Prof. Ananthakrishnan from Harvard Medical School lends credibility to Evinatures work and signals a shift in the perception of integrative therapies.","partners":"Harvard Medical School","customers":"Not mentioned","investors":"Not mentioned","confidence":8,"key_topics":"IBD Treatment, Integrative Therapies, Clinical Trial, CurQD Protocol, Holistic Approach","date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"Growth-Positive","investment_amount":"Not mentioned","structured_issues":"Customers, Partners","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Customers, Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"Growth-Positive","analysisId":"JYOczXtBTzIEQsxreia9GF1ksQZ5T4b2qxQh0LNuKY53dZUNePDWij","news_summary":"Harvard Medical Professor Ashwin Ananthakrishnan Commends Evinature’s CurQD® Trial in CGH Editorial - The European Business Review","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"mpzOUIyCPu20Da9WkOzv7GdVmuVliRO31WFwC6MpSTs4xBR9K6sIVz","date":"Feb 1, 2024","link":"https://www.sciencedirect.com/science/article/abs/pii/S1542356523004457?CMX_ID=&SIS_ID=&dgcid=STMJ_AUTH_SERV_PUBLISHED&utm_acid=274592286&utm_campaign=STMJ_AUTH_SERV_PUBLISHED&utm_in=DM380756&utm_medium=email&utm_source=AC_","source":"www.sciencedirect.com","visible":1,"analysis":{"tags":"Clinical Trial, Herbal Medicine","company":"EviNature","layoffs":"Not mentioned","summary":"A clinical trial was conducted to evaluate the efficacy of a herbal combination of curcumin-QingDai (CurQD) in treating active ulcerative colitis (UC). The study was conducted in Israel and Greece and showed positive results with CurQD inducing response and remission in active UC patients. The trial was supported by the Alan B. Slifka Foundation and a private donation from the Mousseif family. The study suggests that the aryl-hydrocarbon receptor pathway, which CurQD activates, may be a potential treatment target for UC. EviNature, a spin-off company of Sheba Center, has filed for intellectual property rights on the combination of curcumin and QD.","partners":"Sheba Medical Center, Tel-Aviv University, Evangelismos-Polykliniki’ General Hospital of Athens","customers":"Not mentioned","investors":"Alan B. Slifka Foundation, Mousseif family","confidence":9,"key_topics":"Ulcerative Colitis, Curcumin-QingDai, Clinical Trial, Herbal Medicine, Treatment Efficacy","date_of_event":"2023-05-23","valuation_amount":"Not mentioned","impact_on_company":"Growth-Positive","investment_amount":"Not mentioned","structured_issues":"Investment, Partners","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment, Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"Growth-Positive","analysisId":"YIXsosqh7EWDhfAxtEdgnL8u3SFWofGULrs4tCjvGGiQnssAa3KXqA","news_summary":"Curcumin-QingDai Combination for Patients With Active Ulcerative Colitis: A Randomized, Double-Blinded, Placebo-Controlled Trial","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"BOrvF3jsy3xCoFJnaTdCvxIGgYJJafXanyh7pqlVNhcIGsd7gf8aob","date":"Jan 22, 2024","link":"https://www.biopharmadive.com/press-release/20240122-evinatures-divertx-a-revolutionary-natural-approach-to-post-diverticuliti/","source":"www.biopharmadive.com","visible":1,"analysis":{"tags":"Healthcare, Product Launch","company":"Evinature","layoffs":"N/A","summary":"Healthcare startup Evinature has launched DivertX, a natural treatment for Post-Diverticulitis Syndrome (PDS). The product is designed to fill a gap in diverticulitis care, offering a preventive strategy for patients experiencing lingering symptoms after acute episodes. Evinature, known for its product CurQD®, which aids those suffering from Inflammatory Bowel Disease (IBD), has ventured into new territory with DivertX. The product combines two herbal compounds, Curcuma Longa and Coptis Chinensis, to target mucosal inflammation, bacterial imbalance, and IBS-like symptoms associated with PDS. Evinature is currently in phase 2 of their ongoing clinical trial for DivertX.","partners":"N/A","customers":"Patients with Post-Diverticulitis Syndrome (PDS)","investors":"N/A","confidence":9,"key_topics":["DivertX Launch","Post-Diverticulitis Syndrome","Healthcare Innovation","Clinical Trials","Natural Treatment"],"date_of_event":"1st of February","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Customers, Expand","acquisition_amount":"N/A","structuredIssuesShow":"#Customers, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Sv6YK30s4cCu9MdyC6olYdgDvJXUUqWJYszufRhwUE0ScQmJyOzEvk","news_summary":"Evinature's DivertX: A Revolutionary Natural Approach to Post-Diverticulitis Syndrome | BioPharma Dive","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"86afzoTf5LxhPbGJmeKCYDkfMlIiMNnEcd6wgC9AB8sVGalNb5QVVv","date":"Jan 8, 2024","link":"https://thebossmagazine.com/74-year-old-melissa-mckown-finds-ibd-relief-with-evinatures-curqd-protocol/","source":"thebossmagazine.com","visible":1,"analysis":{"tags":"Healthcare, Research, IBD Treatment","company":"Evinature","layoffs":"N/A","summary":"Evinature, a pioneer in Inflammatory Bowel Disease (IBD) treatment, has developed the CurQD® Protocol, a natural treatment regime that has been integrated into standard clinical practice in leading medical centers in Israel. The company recently conducted an interview with an IBD patient, Melissa McKown, who found relief in the CurQD® Protocol after a challenging journey with ulcerative colitis. Melissas experience highlights the life-changing impact of the CurQD® Protocol on the overall well-being of IBD patients.","partners":"N/A","customers":"Melissa McKown","investors":"N/A","confidence":9,"key_topics":["Inflammatory Bowel Disease (IBD) Treatment","CurQD® Protocol","Patient Experience","Natural Medicine","Treatment Efficacy"],"date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Customers","acquisition_amount":"N/A","structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"XTh5xkK6LqiYQcwaRcDWcEJdMlx9NwZDWA81l8pIz0qkJTFHwLEHUQ","news_summary":"74-Year-Old Melissa McKown Finds IBD Relief with Evinature's CurQD® Protocol","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"BzcNprIP3wElvYHzvJPBaLlr3g87QDPqXXWC2KhXQ7V71wESBV1PGN","date":"Jan 1, 2024","link":"https://pubmed.ncbi.nlm.nih.gov/39279191/","source":"pubmed.ncbi.nlm.nih.gov","visible":1,"analysis":{"tags":"clinical trial","company":null,"layoffs":null,"summary":"The article discusses a clinical trial investigating the efficacy of a Curcumin-QingDai combination for patients with active ulcerative colitis. This study is a randomized, double-blinded, placebo-controlled trial conducted by a team of researchers including Ben-Horin S, Salomon N, and others. The trial results are published in the Clinical Gastroenterology and Hepatology journal, with the study set to appear in the February 2024 issue. The research aims to provide insights into potential new treatments for ulcerative colitis, a chronic inflammatory bowel disease.","partners":null,"customers":null,"investors":null,"confidence":10,"key_topics":["Curcumin","QingDai","Ulcerative Colitis","Randomized Trial","Placebo-Controlled"],"date_of_event":"2023-06-09","valuation_amount":null,"impact_on_company":null,"investment_amount":null,"structured_issues":[],"acquisition_amount":null,"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"ZO0xjgoKDGREf8NIraEA8Z1HGBYKbOmiEddxsaMzIMgQMZf6YlOpnF","news_summary":"NCBI - WWW Error Blocked Diagnostic","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"jxY38iHOQm5vZrpMYCKSLKVoQqFtsfOHzIXgWn5oe0bbsYDKVkFX0W","date":"Dec 14, 2023","link":"https://www.msn.com/en-us/news/other/the-curqd%C2%AE-effect-ibd-patient-rafal-majorczyk-talks-about-his-transformative-journey-with-evinature/ar-AA1luFTO?disableErrorRedirect=true&infiniteContentCount=0","source":"www.msn.com","visible":1,"analysis":null,"sentiment":null,"analysisId":"suAC8tRkPnCAIUJnHUGQg7cdz0SvkA9kgbENWljGXxxvn4gzJt22HP","news_summary":"The CurQD® Effect: IBD Patient Rafal Majorczyk Talks About His Transformative Journey With Evinature\n","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"none"},{"id":"p6bOe5BB6IbyC78m4J3JjJSTB9DdR9LilQ5HT8VMGDhggU96Bp5pLK","date":"Dec 12, 2023","link":"https://podcasts.apple.com/us/podcast/episode-156-new-and-promising-nutraceutical/id1532328889?i=1000633972274","source":"podcasts.apple.com","visible":1,"analysis":{"tags":"Healthcare, Nutraceuticals","company":"Sheba Medical Center","layoffs":"N/A","summary":"Nir Salomon, director of integrative gastroenterology at Sheba Medical Center, and his research team have developed CurQD, a nutraceutical supplement designed to heal the mucosal layer of the intestines. This supplement is aimed at treating conditions such as Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS). The podcast episode discusses the development of these nutraceuticals and their intended users. It also explores the potential for CurQD to be used in conjunction with pharmaceuticals like antibiotics or immunosuppressants.","partners":"N/A","customers":"Patients with IBD and IBS","investors":"N/A","confidence":8,"key_topics":"Inflammatory Bowel Disease, Irritable Bowel Syndrome, CurQD, Nutraceuticals, Pharmaceuticals","date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Customers","acquisition_amount":"N/A","structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"yJVtJmucRyZppfcMWTwqT4wWdcDuGrroAORomSIuFqoNoXjDsLHMcp","news_summary":"‎Optimal Metabolism: Episode 156- NEW and Promising Nutraceutical Treatments for IBD and IBS with Nir Salomon on Apple Podcasts","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"A8IqpHNr4iWWGHmMJ3upZhiW52eXoKi97ihYw2Rmc6jX4mL2GQ6ebQ","date":"Dec 11, 2023","link":"https://nyweekly.com/health/a-triumph-with-evinatures-curqd-protocol-kaleigh-castiellos-journey-to-natural-remission/","source":"nyweekly.com","visible":1,"analysis":{"tags":"Healthcare, Treatment","company":"Evinature","layoffs":"N/A","summary":"KaLeigh Castiello, a personal trainer diagnosed with ulcerative colitis (UC), shares her journey to remission using Evinatures CurQD Protocol. After her diagnosis in 2020, Castiello explored various treatments, including conventional medication and naturopathic approaches, but found them ineffective. In 2022, she discovered Evinature and its CurQD Protocol, developed by founders Professor Shomron Ben-Horin and Nir Salomon. Within six weeks of starting the protocol, her symptoms began to recede. Today, she maintains her remission with a combination of CurQD and mesalamine, successfully avoiding the need for biologics.","partners":"N/A","customers":"KaLeigh Castiello","investors":"N/A","confidence":9,"key_topics":"IBD Treatment, CurQD Protocol, Natural Remission, Ulcerative Colitis","date_of_event":"2022","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Customers","acquisition_amount":"N/A","structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"HGWbxbdPc79UqGxT1IvvvKk5ultD0RBi8SbrjNuemOq82eCYZMlHfk","news_summary":"A Triumph with Evinature's CurQD® Protocol: KaLeigh Castiello's Journey to Natural Remission - New York Weekly","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"U6KQxnQAzt7WNk4tXpLgFx4NF0RR0fm3kHQ3ahZRnufCmAwa1TBHwx","date":"Nov 8, 2023","link":"https://www.biopharmadive.com/press-release/20231108-empowered-and-informed-evinatures-pioneering-role-in-ibd-patient-educatio-1/","source":"www.biopharmadive.com","visible":1,"analysis":{"tags":"Patient Education, Chronic Illness Management","company":"Evinature","layoffs":"NA","summary":"Evinature, a healthcare company, is emphasizing the importance of patient education in managing chronic illnesses like Inflammatory Bowel Disease (IBD). The company believes that well-informed patients can improve medication adherence, reduce anxiety and depression, enhance their overall quality of life, and actively participate in their treatment plans. Evinature provides comprehensive, accessible, and up-to-date information on conditions like IBD and the latest advancements in healthcare. The company also hosts monthly webinars to educate patients about their health and well-being.","partners":"NA","customers":"Patients with IBD","investors":"NA","confidence":9,"key_topics":["Patient Education","Chronic Illness","Webinar","Healthcare","IBD"],"date_of_event":"NA","valuation_amount":"NA","impact_on_company":"growth-positive","investment_amount":"NA","structured_issues":["Customers"],"acquisition_amount":"NA","structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"L2IsXtWHvWaWk3qz1JKS8SkPeot3CjoRK19oDhIJUR0mqyzhXyBOYH","news_summary":"Empowered and Informed: Evinature's Pioneering Role in IBD Patient Education | BioPharma Dive","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"icWoycYR5Wk5mL3epmDgcwYVYPwkOo6UPqImksVlMEDtqRKPOVoPzk","date":"Sep 21, 2023","link":"https://thechicagojournal.com/evinatures-clinic-support-introduces-a-new-era-of-ibd-patient-care/","source":"thechicagojournal.com","visible":1,"analysis":{"tags":"Healthcare, Customer Support","company":"Evinature","layoffs":"N/A","summary":"Healthcare startup Evinature has launched Clinic Support, a customer success model that provides comprehensive patient care, including check-ins, follow-ups, adjustments, personal support, and patient/product education. The service is designed to provide a more personalized approach to treating gastrointestinal disorders, with a focus on individual patient needs and responses to supplements. The companys team is dedicated to providing emotional support and credible medical information to patients, and the service has received positive feedback from users.","partners":"N/A","customers":"Mr. Gonzalez, Alexa Taylor, Heather Odom, Robin Schwarz","investors":"N/A","confidence":9,"key_topics":"IBD, Supplements, Patient Care, Clinic Support","date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Customers","acquisition_amount":"N/A","structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"P5c6uYv9Ux2AbJD3qZXoinxXBDaQhFROgJdKG30OYdSs6cFtmk3Se3","news_summary":"Evinature’s Clinic Support Introduces A New Era of IBD Patient Care - The Chicago Journal","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"NlD3m4VSFsOJ6NhXkMzjt3VxCeCQjAOG5dPSEvXKfBpw3UhAMXQhxz","date":"Sep 19, 2023","link":"https://miamiwire.com/why-evinature-is-making-lots-of-noise-on-reddit/","source":"miamiwire.com","visible":1,"analysis":{"tags":"Healthcare, Alternative Medicine","company":"Evinature","layoffs":"N/A","summary":"Evinature, an Israel-based healthcare startup, is making strides in the treatment of Inflammatory Bowel Disease (IBD) through the use of alternative medicine. The company focuses on developing and distributing nutraceuticals that have been clinically proven to help manage IBD symptoms. Their product, The CurQD Protocol, has been gaining attention on Reddit, with users sharing their positive experiences and the effectiveness of the treatment. Evinature provides its services through an online platform, making it accessible to patients worldwide.","partners":"N/A","customers":["DigitalPoverty","James Wayne","kaybemcgee","MichelleInNH"],"investors":"N/A","confidence":9,"key_topics":["IBD Treatment","Alternative Medicine","Patient Testimonials","Online Healthcare","Nutraceuticals"],"date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Customers","acquisition_amount":"N/A","structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"gKNM3VgBa9Dffs7CrC6286GzBLDHy241k16UXuQpNSw4MhrjX8LFgs","news_summary":"Why Evinature is Making Lots of Noise on Reddit - Miami Wire","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"yGzQ3nS72yDKrDYOVg2caKCkPlOK4COBd0YybnJs8Y4CpOtppJ0z3U","date":"Sep 6, 2023","link":"https://valiantceo.com/apan-amos-damri-evinature/","source":"valiantceo.com","visible":1,"analysis":{"tags":"Healthcare, Innovation","company":"Evinature","layoffs":"Not mentioned","summary":"Evinature, a healthcare company led by CEO Apan Amos Damri, is revolutionizing the healthcare industry with innovative nutraceutical solutions. The company is focused on addressing the unmet needs in the treatment of Inflammatory Bowel Disease (IBD) by providing natural solutions. Evinature combines scientific evidence, medical expertise, patient data, and digital tools to provide accessible and effective nutraceuticals to patients worldwide. The company is also unique in that it tailors protocols for individual patients and conducts regular follow-ups, which has been shown to improve patient adherence and outcomes.","partners":"Not mentioned","customers":"Patients with Inflammatory Bowel Disease","investors":"Not mentioned","confidence":8,"key_topics":"Healthcare, Nutraceuticals, Inflammatory Bowel Disease, Digital Tools, Medical Equity","date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":"Customers, Expand","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Customers, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"TczHHBJjcRLKWXFf75A3m0IQ8OIJwNlPW8nCOmqJNj5FC9WpsCj43i","news_summary":"A Spotlight on Apan Amos Damri, CEO of Evinature, and Their Commitment to Wellness","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"9BRThkirPCfQTOYC1bDTDUOlbzWJNDnxthSOmnjPyo5TFIvMwfnF6H","date":"Aug 23, 2023","link":"https://www.msn.com/en-us/news/news/evinature-signs-exclusive-distribution-deal-with-multinational-company-adacyte-therapeutics-to-expand-ibd-treatment-accessibility/ar-AA1fEFmg?disableErrorRedirect=true&infiniteContentCount=0","source":"www.msn.com","visible":1,"analysis":null,"sentiment":null,"analysisId":"23cJZVIkLNLQ6Cyjr5kmzzbZurjgay8jTVYBlUy934W6iGYZRMvEQa","news_summary":"Evinature Signs Exclusive Distribution Deal with Multinational Company Adacyte Therapeutics to Expand IBD Treatment Accessibility","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"none"},{"id":"EoBMz0JXWYmqOQsQynuEbrKTzN98w3EKKDLRm5xbr94wMlIXbphdda","date":"Aug 4, 2023","link":"https://lawire.com/evinatures-curcumin-qingdai-combination-shows-promising-results-to-combat-ibd/","source":"lawire.com","visible":1,"analysis":{"tags":"Healthcare, Research","company":"Evinature","layoffs":"NA","summary":"Evinature, a startup focusing on integrative therapies for inflammatory bowel disease (IBD), has been conducting research on the use of Curcumin-QingDai in treating IBD. The company recently conducted a randomized, double-blinded, placebo-controlled trial, which showed promising results. Evinature also offers a free online assessment to help individuals discover the most effective protocol for their specific needs. The company tracks the progress of each individual and guides them through every stage with regular follow-ups and full clinic support.","partners":"NA","customers":"Patients with active Ulcerative Colitis","investors":"NA","confidence":8,"key_topics":["Inflammatory Bowel Disease","Healthcare Accessibility","Curcumin-QingDai","Clinical Trials","Online Assessment"],"date_of_event":"NA","valuation_amount":"NA","impact_on_company":"growth-positive","investment_amount":"NA","structured_issues":"Customers","acquisition_amount":"NA","structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"HXzTWBIFPqYiV5Dg6vE5tyJhTz7SgnSSAZJAjjd7ve1uDNKFMM9i1A","news_summary":"Evinature’s Curcumin-QingDai Combination Shows Promising Results to Combat IBD - LA Wire","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ap22xe2acocar9q7Q2RC3fNM8U7X1Gu32q7P4AxXAziqSdBE18UKdS","date":"Jul 9, 2023","link":"https://www.msn.com/en-us/news/news/why-the-increasing-global-cases-of-ibd-call-for-this-personalized-and-evidencebased-treatment/ar-AA1e1H6w?disableErrorRedirect=true&infiniteContentCount=0&ocid=socialshare","source":"www.msn.com","visible":1,"analysis":null,"sentiment":null,"analysisId":"KXzUoytj48BnI6gk8k2MdKKTskb4uGyuVx8MeWoPXVpJQTmrUKCAuQ","news_summary":"Why the Increasing Global Cases of IBD Call for this Personalized and Evidence-Based Treatment","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"none"},{"id":"5qJxvFfySoaNfJ6RgzVe3jNDCA5bXZMq7aY016d8Rms8L6iBzE08QU","date":"Jan 8, 2023","link":"https://www.europeanbusinessreview.com/this-natural-medical-protocol-is-revamping-ibd-treatment-globally/","source":"www.europeanbusinessreview.com","visible":1,"analysis":{"tags":"Natural Medicine, IBD Treatment","company":"Evinature","layoffs":"N/A","summary":"Evinature, a company specializing in natural medicine, is offering personalized treatment for patients with inflammatory bowel disease (IBD), Crohn’s, or ulcerative colitis. The company has developed the CurQD Protocol, a collection of natural, clinically-proven regimens that can be accessed from home. The protocol was developed by Professor Shomron Ben-Horin and Nir Salomon of Sheba Medical Center. The CurQD Protocol has undergone extensive testing in clinical trials and has demonstrated a high level of efficacy. The treatment process includes regular follow-ups to ensure patients are benefiting from their protocol and adjustments are made as needed.","partners":"Sheba Medical Center","customers":"Patients with IBD, Crohn’s, or ulcerative colitis","investors":"N/A","confidence":9,"key_topics":"Natural Medicine, IBD, CurQD Protocol, Personalized Treatment, Home-based Care","date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Customers, Expand","acquisition_amount":"N/A","structuredIssuesShow":"#Customers, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"gDmp1e2TPxQ5qduvKDhzfuw9oIPLtJo7tSPnPTY5yQePPeWSwzeVPt","news_summary":"This Natural Medical Protocol is Revamping IBD Treatment Globally - The European Business Review","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"CzWtLUKBROv0LHlxw7jgW18RHxUrBiTIacnEzII0L4YF7Quqah6HOl","date":"Dec 15, 2022","link":"https://www.biopharmadive.com/press-release/20221215-evinature-exits-stealth-with-2-million-funding-to-optimize-global-healthca-1/","source":"www.biopharmadive.com","visible":1,"analysis":{"tags":"integrative therapies","company":"Evinature","layoffs":null,"summary":"Evinature, a startup specializing in integrative therapies for IBD, has emerged from stealth mode with $2 million in funding. The funding round was led by PSC Group, with participation from Ratio technologies, Shay Livnat, and other angel investors. The Israel-based company has launched the Evinature platform, which guides patients through the CurQD Protocol, a natural and tailored treatment regime for IBD. The platform is based on the groundbreaking research of the companys founders, Professor Shomron Ben-Horin, Nir Salomon, and Apan Amos Damri. Evinature aims to integrate modern medical practice with herbal remedies and technology to provide safe, effective, and affordable medicine to people worldwide. The companys main product has been clinically proven to treat Ulcerative Colitis and has been successfully implemented into standard clinical practice in Israel. Evinatures goal is to prioritize patient accessibility to accurate medical assessments and affordable treatments.","partners":null,"customers":null,"investors":["PSC Group","Ratio technologies","Shay Livnat","angel investors"],"confidence":8,"key_topics":["Evinature","CurQD Protocol","IBD","natural supplements","online platform"],"date_of_event":"2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$2 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"xUSzBZQXpjfufGsJhvRtSnwbT66TwNs99BVkT4LkOgJQHqAvqWxR5i","news_summary":"Evinature exits stealth with $2 million funding to optimize global healthcare for patients with IBD, Crohn's, or Colitis through evidence-based natural remedies | BioPharma Dive","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ILsOVZSPIDgorOj2aQ6JKQ5JwKihVxNNdgPHDHMneDQdJFBbaHJ6ci","date":"Nov 25, 2022","link":"https://techbullion.com/how-evinature-spearheads-the-gold-standard-in-evidence-based-natural-remedies-for-ibd-crohns-and-colitis/","source":"techbullion.com","visible":1,"analysis":{"tags":"Healthcare, Research, Treatment","company":"Evinature","layoffs":"Not mentioned","summary":"Evinature, a startup focusing on integrative therapies for gastrointestinal disorders, is aiming to bridge the gap between traditional and modern medicine. The company was founded by Nir Salomon and Professor Shomron Ben-Horin, M.D. after they confirmed the effectiveness of curcumin as a treatment for IBD. Evinature provides a patient-focused platform that offers integrative strategies, guided care, research updates, and vital information. The company emphasizes individualized treatment plans, regular patient reports, and data-driven results. It also stresses the importance of product quality and scientific integrity, distributing only products that have undergone rigorous clinical trials.","partners":"Not mentioned","customers":"Patients with gastrointestinal disorders","investors":"Not mentioned","confidence":9,"key_topics":["Gastrointestinal Disorder","Integrative Therapies","Research","Personalized Treatment","Data-driven Results"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Customers","Expand"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Customers  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"v1X5gl6xwZOaFYUVZrppVRaLUKt3ev9Ma0o3tfIfLtw6MW5DL89vAk","news_summary":"How Evinature Spearheads the Gold Standard in Evidence-Based Natural Remedies for IBD, Crohn's, and Colitis","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"vbi0J1IV8fOj3kKphVApYvnUSsSg0weQpIVMv9XBffwk1S9yhS6mAw","date":"Nov 21, 2022","link":"https://original.newsbreak.com/@market-analysis-1592339/2825958267211-evinature-s-ceo-apan-amos-damr","source":"original.newsbreak.com","visible":1,"analysis":{"tags":"Healthcare, Research","company":"Evinature","layoffs":"Not mentioned","summary":"Evinature, a company specializing in integrated therapies for Inflammatory Bowel Disease (IBD), is developing and distributing clinically-proven nutraceuticals to patients worldwide. The companys goal is to provide accurate diagnosis and treatment through their proprietary online platform. Evinatures products are tested by placebo-controlled trials and are tailored to each patients condition. The companys CurQD protocol, a result of over 10 years of research, has shown exceptional results in inducing remission in ulcerative colitis patients who have not responded to pharmaceutical treatments. Evinature plans to continue developing evidence-based nutraceutical treatments for patients with chronic diseases.","partners":"Not mentioned","customers":"Patients with gastroenterological diseases","investors":"Not mentioned","confidence":9,"key_topics":["Gastroenterological Diseases","Integrated Therapies","Nutraceuticals","Online Platform","Clinical Trials"],"date_of_event":"2022-11-21","valuation_amount":"Not mentioned","impact_on_company":"Growth-Positive","investment_amount":"Not mentioned","structured_issues":["Customers","Expand"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Customers  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"Growth-Positive","analysisId":"KGjOOBaCvLSqnFRoIXMwD2R5uqrF5iy62V4E2JM619WG2xcKeHlf8f","news_summary":"Evinature's CEO Apan Amos Damri On Providing Evidence-Based Natural Remedies to Patients with IBD, Crohn's, and Colitis | Market Analysis | NewsBreak Original","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":38,"techcommunityinvolvement":null,"mediagallery":[{"id":"7X8nBy0grTBa9nZBWf3x62Uj3HS0vwpkAaabsOtrb6ZQIhUhkMwzvj","timestamp":"2025-03-17 08:38:51.000000","resources_type":1,"resources_title":"The CurQD® Protocol - Evinature's flagship nutraceutical strategy for IBD, with different protocols tailored to each patient's needs","resources_file_name":"$3JzjcGgZQvFAEd9VK9OsQCiUgLS2nkXH85n05UwgQyrMqKBEXvUWSy.jpeg","alt":"The CurQD® Protocol - Evinature's flagship nutraceutical strategy for IBD, with different protocols tailored to each patient's needs logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$3JzjcGgZQvFAEd9VK9OsQCiUgLS2nkXH85n05UwgQyrMqKBEXvUWSy.jpeg","url":"https://storage.googleapis.com/clean-finder-353810/$3JzjcGgZQvFAEd9VK9OsQCiUgLS2nkXH85n05UwgQyrMqKBEXvUWSy.jpeg"},{"id":"BnQU9i6ksxB341l8oekHpUaiI8CwUCW391rQL6Y0ygmqoCKA1Dfcpm","timestamp":"2025-03-17 08:38:51.000000","resources_type":1,"resources_title":"Exhale - Balance cortisol levels & Enhance healthy stress response","resources_file_name":"$DSeM3KhMwyZadd931nBmZL5TebJLTsJYw22hjGEHPeEeIJgLcxFnss.jpeg","alt":"Exhale - Balance cortisol levels & Enhance healthy stress response logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$DSeM3KhMwyZadd931nBmZL5TebJLTsJYw22hjGEHPeEeIJgLcxFnss.jpeg","url":"https://storage.googleapis.com/clean-finder-353810/$DSeM3KhMwyZadd931nBmZL5TebJLTsJYw22hjGEHPeEeIJgLcxFnss.jpeg"},{"id":"QX2SyeeKCuWZEeIDzPWOsJtbaq988Tqp7K3b1QopsgFmczUlnRv2fq","timestamp":"2025-03-17 08:38:51.000000","resources_type":1,"resources_title":"Agile - Joint Health & Flexibility","resources_file_name":"$L1pnUJoXjp9Ah4pEodYbzcuPO0U85GwWPJM1IKSmGIqudKk9TKpUSm.jpeg","alt":"Agile - Joint Health & Flexibility logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$L1pnUJoXjp9Ah4pEodYbzcuPO0U85GwWPJM1IKSmGIqudKk9TKpUSm.jpeg","url":"https://storage.googleapis.com/clean-finder-353810/$L1pnUJoXjp9Ah4pEodYbzcuPO0U85GwWPJM1IKSmGIqudKk9TKpUSm.jpeg"},{"id":"UZU0CyRNHOqOIRzL0sGFlJBTfHl9VFV3gEoFmVk8zL3Li5eMnKZ2uI","timestamp":"2025-03-17 08:38:51.000000","resources_type":1,"resources_title":"The CurQD® Protocol - Evinature's flagship nutraceutical strategy for IBD, with different protocols tailored to each patient's needs","resources_file_name":"$XmXXf494OYYdIWk4MiCXXF9qdvmlxzTd4GWtLeRw7lBhvIaL3HweuL.jpeg","alt":"The CurQD® Protocol - Evinature's flagship nutraceutical strategy for IBD, with different protocols tailored to each patient's needs logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$XmXXf494OYYdIWk4MiCXXF9qdvmlxzTd4GWtLeRw7lBhvIaL3HweuL.jpeg","url":"https://storage.googleapis.com/clean-finder-353810/$XmXXf494OYYdIWk4MiCXXF9qdvmlxzTd4GWtLeRw7lBhvIaL3HweuL.jpeg"},{"id":"Ew35p2GWPcd9VDaiELQxRJP47J6sniYcv2ezqU4QUe5xIYrZJGcqHu","timestamp":"2025-03-17 08:38:50.000000","resources_type":1,"resources_title":"The CurQD® Protocol - Evinature's flagship nutraceutical strategy for IBD, with different protocols tailored to each patient's needs","resources_file_name":"$MZuafelqW3gCdI8r6ttShL0jjMSejprNqHkGvHrErEtTW1I415xALV.jpeg","alt":"The CurQD® Protocol - Evinature's flagship nutraceutical strategy for IBD, with different protocols tailored to each patient's needs logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$MZuafelqW3gCdI8r6ttShL0jjMSejprNqHkGvHrErEtTW1I415xALV.jpeg","url":"https://storage.googleapis.com/clean-finder-353810/$MZuafelqW3gCdI8r6ttShL0jjMSejprNqHkGvHrErEtTW1I415xALV.jpeg"},{"id":"IaaaznD9g7mXWLXAKbLoL117ECC867nMU04Atj5xQpMTCvtvw2EK5M","timestamp":"2025-03-17 08:38:50.000000","resources_type":1,"resources_title":"Cura - Gut-directed Curcumin","resources_file_name":"$X9wCknh5uAJ357e2e4OPJXU649HJkA3WNA7NiouB9GYNN9mkS454mp.jpeg","alt":"Cura - Gut-directed Curcumin logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$X9wCknh5uAJ357e2e4OPJXU649HJkA3WNA7NiouB9GYNN9mkS454mp.jpeg","url":"https://storage.googleapis.com/clean-finder-353810/$X9wCknh5uAJ357e2e4OPJXU649HJkA3WNA7NiouB9GYNN9mkS454mp.jpeg"},{"id":"cT4FfcMSboHMaz1WcWdmriny10YxYpBAQyBL51rwWA0K7cDiXDNUtK","timestamp":"2025-03-17 08:38:50.000000","resources_type":1,"resources_title":"The CurQD® Protocol - Evinature's flagship nutraceutical strategy for IBD, with different protocols tailored to each patient's needs","resources_file_name":"$Qc3mBsde6jy28yv7gIn64Upzq4viZ6S2Psp7925gmDznsmRi9HsPGn.png","alt":"The CurQD® Protocol - Evinature's flagship nutraceutical strategy for IBD, with different protocols tailored to each patient's needs logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$Qc3mBsde6jy28yv7gIn64Upzq4viZ6S2Psp7925gmDznsmRi9HsPGn.png","url":"https://storage.googleapis.com/clean-finder-353810/$Qc3mBsde6jy28yv7gIn64Upzq4viZ6S2Psp7925gmDznsmRi9HsPGn.png"},{"id":"clUpaJJCXDpTnyxHzY1L8P3uqOOVtFkTkONkaSHvz0ju28JMimQcMP","timestamp":"2025-03-17 08:38:50.000000","resources_type":1,"resources_title":"QD1 - Indigo Naturalis, Qing Dai","resources_file_name":"$oNUkkNsbCE5blUz3cxmTPFmceKRFLAu0PDKhvXTFP5KzcDO3Vxd1yu.jpeg","alt":"QD1 - Indigo Naturalis, Qing Dai logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$oNUkkNsbCE5blUz3cxmTPFmceKRFLAu0PDKhvXTFP5KzcDO3Vxd1yu.jpeg","url":"https://storage.googleapis.com/clean-finder-353810/$oNUkkNsbCE5blUz3cxmTPFmceKRFLAu0PDKhvXTFP5KzcDO3Vxd1yu.jpeg"},{"id":"nEU9R77odGy3dhL3FI9uTzLUwlD8mTThZYirMpFRzaz4BTvkTQxUjx","timestamp":"2025-03-17 08:38:50.000000","resources_type":1,"resources_title":"The CurQD® Protocol - Evinature's flagship nutraceutical strategy for IBD, with different protocols tailored to each patient's needs","resources_file_name":"$BVm14ykAhH6cuBe8zZWjYFRJJ7v809WMfn7xjfZWp01YE6O0Ctwxc2.jpeg","alt":"The CurQD® Protocol - Evinature's flagship nutraceutical strategy for IBD, with different protocols tailored to each patient's needs logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$BVm14ykAhH6cuBe8zZWjYFRJJ7v809WMfn7xjfZWp01YE6O0Ctwxc2.jpeg","url":"https://storage.googleapis.com/clean-finder-353810/$BVm14ykAhH6cuBe8zZWjYFRJJ7v809WMfn7xjfZWp01YE6O0Ctwxc2.jpeg"},{"id":"qJbQMOuezyR8xeHKicjGbnAhU4DnY38H1vG09BsXZKs2YRhlS5UuOU","timestamp":"2025-03-17 08:38:50.000000","resources_type":1,"resources_title":"DivertX - formulated for diverticulitis and IBS","resources_file_name":"$D25br68BKMy39K81VOCPcH8j2A5Zt2w2TpehH8HMX91nS2nWp9dquk.jpeg","alt":"DivertX - formulated for diverticulitis and IBS logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$D25br68BKMy39K81VOCPcH8j2A5Zt2w2TpehH8HMX91nS2nWp9dquk.jpeg","url":"https://storage.googleapis.com/clean-finder-353810/$D25br68BKMy39K81VOCPcH8j2A5Zt2w2TpehH8HMX91nS2nWp9dquk.jpeg"},{"id":"k5qvoL3hzI9Sq4pLbXXXKlWJ6eXvgQEs17T7GhB5O0e2ZFusW2j1u3","timestamp":"2025-02-06 13:05:10.000000","resources_type":1,"resources_title":"DivertX - formulated for diverticulitis and IBS","resources_file_name":"$0mnHItjhwMVjIkbrE0cjbRDjGXegMSfbW3ip0fXqO2OmCQMIB9b0yp.webp","alt":"DivertX - formulated for diverticulitis and IBS logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$0mnHItjhwMVjIkbrE0cjbRDjGXegMSfbW3ip0fXqO2OmCQMIB9b0yp.webp","url":"https://storage.googleapis.com/clean-finder-353810/$0mnHItjhwMVjIkbrE0cjbRDjGXegMSfbW3ip0fXqO2OmCQMIB9b0yp.webp"},{"id":"3vb6PMsrTbDWrF04CQUoJ9ViNRo7epXhSgyZvPcqNUzOA2AA6usNYE","timestamp":"2024-05-27 10:48:47.000000","resources_type":2,"resources_title":"Patient Stories - the impact of Evinature","resources_file_name":"wjVt6pyJrlA","alt":"Patient Stories - the impact of Evinature logo","imageurl":"https://img.youtube.com/vi/wjVt6pyJrlA/0.jpg","url":"http://youtu.be/wjVt6pyJrlA"}],"tags":["supplements","medical-products","mental-health","pharmaceuticals","gastroenterology","treatments","inflammatory-diseases","crohn's-disease","nutraceuticals"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQlIIIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA"],"technologysuccessstory":null,"usecases":[{"id":"1tULxGJLTPD6h7XDPEiaQE47ZEhf0hC7Ti1Xt9FOSAPPwZ6eaiyMnf","link":"https://vimeo.com/showcase/10659685/video/951010784","name":"Kaleigh's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T18:29:36.127Z","Revenue Growth":3,"Risk Mitigation":1,"Industry Vertical":"Health & Wellness","ready_for_display":false,"Talent Development":1,"Agility & Innovation":3,"Customer Acquisition":4,"Operational Efficiency":1,"Short Solution Description":"Evinature provides natural dietary supplements, specifically for gut health conditions like SIBO, offering an effective solution for individuals seeking relief and improved well-being."}},{"id":"3cfRU5xZkZiyYSNnwhdaXUUczrm1zbaL34fT68sqb47WJMeDcjiign","link":"https://vimeo.com/showcase/10659685/video/875153917","name":"Megan's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T18:41:59.068Z","Revenue Growth":4,"Risk Mitigation":1,"Industry Vertical":"Health & Wellness","ready_for_display":false,"Talent Development":2,"Agility & Innovation":3,"Customer Acquisition":5,"Operational Efficiency":1,"Short Solution Description":"Evinature provides natural dietary supplements and protocols, specifically for gut health conditions like SIBO, offering an effective and supportive solution for individuals seeking relief from chronic digestive issues."}},{"id":"8ClnMYH32AWhCyFKnuVhlibr0kVq0lgrmzm5BrzyZYzIzVwdwX6H5j","link":"https://vimeo.com/showcase/10659685/video/946960525","name":"LJ's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T19:14:32.709Z","Revenue Growth":3,"Risk Mitigation":3,"Industry Vertical":"Hospitality & Food Service","ready_for_display":false,"Talent Development":3,"Agility & Innovation":3,"Customer Acquisition":3,"Operational Efficiency":4,"Short Solution Description":"Evinature offers an on-site organic waste processing solution that converts food waste into a soil amendment, significantly reducing waste volume, eliminating odors and pests, and lowering disposal costs for businesses."}},{"id":"D2IEJDlggJEubRD6KwzNgfIECiLhRS9qq9RKntAgZ2eJ0PNCayRBAb","link":"https://vimeo.com/showcase/10659685/video/901461712","name":"Sharon's Son's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T19:37:13.864Z","Revenue Growth":3,"Risk Mitigation":2,"Industry Vertical":"Health & Wellness","ready_for_display":false,"Talent Development":1,"Agility & Innovation":1,"Customer Acquisition":4,"Operational Efficiency":1,"Short Solution Description":"A customer testimonial video featuring a mother sharing her son's positive experience with Evinature's natural supplements for Crohn's disease, serving as a powerful marketing and trust-building asset."}},{"id":"E6dGinCwXmMrv3gVn7Lusz5ET8Orp16C7L4Pf2j46m3vpHuPFSb2UD","link":"https://vimeo.com/showcase/10659685/video/893023440","name":"Shahar's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T19:41:34.289Z","Revenue Growth":3,"Risk Mitigation":2,"Industry Vertical":"Healthcare","ready_for_display":false,"Talent Development":1,"Agility & Innovation":1,"Customer Acquisition":4,"Operational Efficiency":1,"Short Solution Description":"Evinature provides natural, evidence-based solutions for digestive health conditions like IBS. The video features a customer testimonial highlighting the product's effectiveness in improving symptoms and quality of life."}},{"id":"EUpxUXqLjEZIWeINVuclaPOZnoKejjv8hjhFKL1ZwgbJyFOpq5QkDz","link":"https://vimeo.com/showcase/10659685/video/976360035","name":"Devang's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T19:44:36.007Z","Revenue Growth":4,"Risk Mitigation":3,"Industry Vertical":"E-commerce / Retail","ready_for_display":false,"Talent Development":3,"Agility & Innovation":4,"Customer Acquisition":3,"Operational Efficiency":5,"Short Solution Description":"Evinature provides an end-to-end e-commerce management solution for small businesses, handling online store setup, product listings, inventory, order fulfillment, and customer service, allowing business owners to focus on core operations."}},{"id":"GiXXgMb2poTtVsGGSQqKBR0Y8UPEciUswvG4MywqL4DH8ik8LalwV9","link":"https://vimeo.com/showcase/10659685/video/865623356","name":"Elizabeth's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T19:56:07.245Z","Revenue Growth":4,"Risk Mitigation":2,"Industry Vertical":"Nutraceuticals","ready_for_display":false,"Talent Development":1,"Agility & Innovation":4,"Customer Acquisition":5,"Operational Efficiency":1,"Short Solution Description":"Evinature provides evidence-based natural supplements and protocols for individuals suffering from chronic digestive health issues like SIBO, offering an effective alternative to traditional treatments and significantly improving quality of life."}},{"id":"JkrfE20t0qjtXUWfiTwKMmYVHU3HCiyw9bzHXgthgnBrBQWuHNJq39","link":"https://vimeo.com/showcase/10659685/video/865622775","name":"Heidi's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T20:09:56.190Z","Revenue Growth":3,"Risk Mitigation":1,"Industry Vertical":"Healthcare / Wellness","ready_for_display":false,"Talent Development":1,"Agility & Innovation":3,"Customer Acquisition":4,"Operational Efficiency":1,"Short Solution Description":"Evinature provides natural, evidence-based dietary supplements, such as Biome-Heal and Biome-Clear, designed to alleviate chronic digestive issues like IBS and SIBO, significantly improving customers' quality of life and dietary freedom."}},{"id":"Jn4M8UyFEuiSaReXQhoS4FQxV3GK0PTzPjpD50L03XrKp5BUN1Ubd3","link":"https://vimeo.com/showcase/10659685/video/893626081","name":"Tal's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T20:10:20.172Z","Revenue Growth":4,"Risk Mitigation":4,"Industry Vertical":"Healthcare","ready_for_display":false,"Talent Development":3,"Agility & Innovation":5,"Customer Acquisition":5,"Operational Efficiency":4,"Short Solution Description":"Evinature develops evidence-based natural solutions for chronic diseases, starting with IBD, delivered through a personalized digital clinic model that combines natural compounds, clinical research, and data science to provide effective and safe treatments."}},{"id":"KwTl35zKeincr6bTYIynwX4FlWbwgTW5R1mH6Q9ZZJ1x1V4Pi6FEim","link":"https://vimeo.com/showcase/10659685/video/950999606","name":"Moses's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T20:15:07.028Z","Revenue Growth":4,"Risk Mitigation":1,"Industry Vertical":"Health & Wellness","ready_for_display":false,"Talent Development":1,"Agility & Innovation":2,"Customer Acquisition":5,"Operational Efficiency":1,"Short Solution Description":"Evinature provides natural health supplements, specifically highlighted for their effectiveness in treating gut health issues like SIBO, as demonstrated through a customer's successful recovery story."}},{"id":"L1cN2Qqm4pOFaMin0QeV81DLj7zIawWMrUsLk8n9yqXtumkig7hI57","link":"https://vimeo.com/showcase/10659685/video/879128575","name":"Lucy's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T20:15:50.717Z","Revenue Growth":3,"Risk Mitigation":1,"Industry Vertical":"Health & Wellness","ready_for_display":false,"Talent Development":1,"Agility & Innovation":2,"Customer Acquisition":4,"Operational Efficiency":1,"Short Solution Description":"Evinature offers natural dietary supplements, like Evincap, to help individuals effectively manage and alleviate symptoms of gut health conditions such as Irritable Bowel Syndrome (IBS), as demonstrated through customer testimonials."}},{"id":"Lvll9MbtoVB8cyurpn5MfROfHEouSAilFtwV1cv2qlYUKUlz1HjRJz","link":"https://vimeo.com/showcase/10659685/video/865622389","name":"Rodrigo's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T20:20:41.405Z","Revenue Growth":4,"Risk Mitigation":1,"Industry Vertical":"Health & Wellness / Nutraceuticals","ready_for_display":false,"Talent Development":2,"Agility & Innovation":3,"Customer Acquisition":5,"Operational Efficiency":2,"Short Solution Description":"Evinature provides natural health protocols and personalized support (dietitians, health coaches) for individuals suffering from chronic digestive issues, as highlighted by a customer testimonial showcasing significant health improvement."}},{"id":"NaQABYwtndytEshu8bQMQqfm8oh1GZnz1xZ1QyzLbHxf0ybdg3OPsY","link":"https://vimeo.com/showcase/10659685/video/871013331","name":"Trish's Evinature Story","ai_analysis":{"Confidence":0.8,"created_at":"2025-07-22T20:28:06.302Z","Revenue Growth":4,"Risk Mitigation":3,"Industry Vertical":"Healthcare / Natural Health Products","ready_for_display":false,"Talent Development":1,"Agility & Innovation":4,"Customer Acquisition":5,"Operational Efficiency":1,"Short Solution Description":"Evinature offers natural, plant-based treatment protocols for Inflammatory Bowel Disease (IBD), providing an effective and safe alternative to traditional medications for patients seeking symptom relief and improved quality of life."}},{"id":"UKhKNqlPV4kz7TnZr7bjclxPnjrRZj2oHYrQi7Mxx2QMc2K4JCSU38","link":"https://vimeo.com/showcase/10659685/video/917829378","name":"Katie's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T20:57:57.381Z","Revenue Growth":4,"Risk Mitigation":1,"Industry Vertical":"Healthcare","ready_for_display":false,"Talent Development":1,"Agility & Innovation":4,"Customer Acquisition":5,"Operational Efficiency":1,"Short Solution Description":"Evinature provides natural, evidence-based protocols and supplements for gut health, particularly for conditions like SIBO, offering an effective alternative to conventional treatments and significantly improving patients' quality of life."}},{"id":"WcK6RONQhpN3uPnNHA047kB9bcOoeMAGh0n60gSQZEaqbcYzwvoBOj","link":"https://vimeo.com/showcase/10659685/video/890999461","name":"Diane's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T21:05:15.052Z","Revenue Growth":3,"Risk Mitigation":1,"Industry Vertical":"Health & Wellness","ready_for_display":false,"Talent Development":1,"Agility & Innovation":3,"Customer Acquisition":5,"Operational Efficiency":1,"Short Solution Description":"Evinature provides natural health supplements, particularly for gut health conditions like IBS and SIBO, offering an effective alternative solution for individuals seeking relief and improved well-being."}},{"id":"YPPjsXIUyMJcpBtIGyNRlNLRR131B9Lqjh8SID3t2pRqX6NfMOHlKh","link":"https://vimeo.com/showcase/10659685/video/900767190","name":"Yazmin's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T21:14:42.361Z","Revenue Growth":3,"Risk Mitigation":1,"Industry Vertical":"Health & Wellness","ready_for_display":false,"Talent Development":2,"Agility & Innovation":2,"Customer Acquisition":5,"Operational Efficiency":1,"Short Solution Description":"Evinature offers natural dietary supplements, specifically for gut health conditions like SIBO, complemented by customer support and health coaching, as demonstrated by a customer's successful recovery and improved quality of life."}},{"id":"YgC4g6Z5NcT8pwJo1sPLTAsbdvaGyJmBGyDAHI9n3JWHQblntwKe1X","link":"https://vimeo.com/showcase/10659685/video/903634551","name":"Miroslava's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T21:15:51.866Z","Revenue Growth":3,"Risk Mitigation":4,"Industry Vertical":"Healthcare / Wellness","ready_for_display":false,"Talent Development":1,"Agility & Innovation":3,"Customer Acquisition":4,"Operational Efficiency":2,"Short Solution Description":"Evinature provides science-backed, clinically tested natural supplements that holistic and functional medicine practitioners trust to deliver effective patient outcomes, enhancing patient satisfaction and mitigating treatment risks."}},{"id":"bbFImh9DWUyQfriN6eam7U17TCUZFTSoOnETsuagp72XN9bDsSfXyh","link":"https://vimeo.com/showcase/10659685/video/865622584","name":"Hannah's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T21:32:50.334Z","Revenue Growth":3,"Risk Mitigation":1,"Industry Vertical":"Healthcare & Wellness","ready_for_display":false,"Talent Development":1,"Agility & Innovation":2,"Customer Acquisition":4,"Operational Efficiency":1,"Short Solution Description":"Evinature provides natural, evidence-based supplements, such as SIBO-MMC and SIBO-Rebuild, to help individuals manage and recover from gut health issues like SIBO and IBS, supported by customer care."}},{"id":"eIPeSlm8kREGI2KghJIntpJSzdWAjNocj47sNDEQ0rK4N1C8uab2H9","link":"https://vimeo.com/showcase/10659685/video/865621766","name":"Kaeleigh's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T21:47:48.163Z","Revenue Growth":4,"Risk Mitigation":3,"Industry Vertical":"Healthcare / Nutraceuticals","ready_for_display":false,"Talent Development":1,"Agility & Innovation":2,"Customer Acquisition":5,"Operational Efficiency":1,"Short Solution Description":"Evinature offers science-backed natural supplements, like Curcumin and Boswellia, designed to help individuals manage inflammatory bowel diseases such as Crohn's and Ulcerative Colitis, improving their quality of life and reducing reliance on traditional medications."}},{"id":"eW8fLfIkToA8XnHpxecXIKHz90TnBUUIGhs0oANVknU4xg46TjAhzH","link":"https://vimeo.com/showcase/10659685/video/865622495","name":"Alex's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T21:48:41.307Z","Revenue Growth":4,"Risk Mitigation":2,"Industry Vertical":"Health & Wellness","ready_for_display":false,"Talent Development":2,"Agility & Innovation":3,"Customer Acquisition":5,"Operational Efficiency":1,"Short Solution Description":"Evinature offers natural supplements for gut health conditions like SIBO and IBS, combined with personalized health coaching and customer support, as highlighted by a customer's successful recovery story."}},{"id":"ffEutvNvffhwl6jPpKVTn0PcDHKfXYQ3kLYRL9Z3Tq7veuZB6LgxtW","link":"https://vimeo.com/showcase/10659685/video/899767174","name":"Amy's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T21:54:42.058Z","Revenue Growth":3,"Risk Mitigation":1,"Industry Vertical":"Health & Wellness","ready_for_display":false,"Talent Development":1,"Agility & Innovation":3,"Customer Acquisition":5,"Operational Efficiency":1,"Short Solution Description":"Evinature provides natural health solutions, specifically supplements and protocols for gut health conditions like SIBO, aiming to significantly improve customers' well-being and quality of life. The video showcases a customer's transformative journey and the profound positive impact of the solution."}},{"id":"mvr4ZAMdEUdDk1va5nXzrSdFrP0UrqeH4cy5yCuwjf0kB9UG6Gmekz","link":"https://vimeo.com/showcase/10659685/video/866735544","name":"Alexa's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T22:25:24.311Z","Revenue Growth":3,"Risk Mitigation":1,"Industry Vertical":"Health & Wellness","ready_for_display":false,"Talent Development":2,"Agility & Innovation":2,"Customer Acquisition":4,"Operational Efficiency":1,"Short Solution Description":"Evinature provides natural health supplements and personalized support (health coaching, customer service) for gut health conditions like SIBO and IBS, as highlighted by customer testimonials."}},{"id":"nTGxbE38BJRrr1EfSYHhgd00bn1RHDX1LE4PJ432IK8f4CDID2jyWN","link":"https://vimeo.com/showcase/10659685/video/915144832","name":"Carly's Evinature Story","ai_analysis":{"Confidence":0.7,"created_at":"2025-07-22T22:28:07.741Z","Revenue Growth":3,"Risk Mitigation":3,"Industry Vertical":"Natural Health Products","ready_for_display":false,"Talent Development":1,"Agility & Innovation":3,"Customer Acquisition":4,"Operational Efficiency":1,"Short Solution Description":"Evinature offers natural health solutions, particularly for gut health conditions like SIBO and IBS, which are highlighted through patient testimonials demonstrating significant improvements in health and quality of life."}},{"id":"p8DACwYTQZLSVXg6GhIOfHwOyuqWCsOb5QRZ88Jz9ndRzX7OIgclh1","link":"https://vimeo.com/showcase/10659685/video/865622869","name":"Sheryl's Evinature Story","ai_analysis":{"Confidence":0.8,"created_at":"2025-07-22T22:36:32.669Z","Revenue Growth":4,"Risk Mitigation":1,"Industry Vertical":"Health & Wellness","ready_for_display":false,"Talent Development":1,"Agility & Innovation":4,"Customer Acquisition":5,"Operational Efficiency":1,"Short Solution Description":"Evinature provides a health solution, likely a program or product, that effectively alleviates symptoms of Irritable Bowel Syndrome (IBS), significantly improving the quality of life and digestive health for individuals who have struggled with the condition for years."}},{"id":"q0jGmIZkcKh2QIRv82L6z3BYNn2WMhu35GCtQLTTuG34nPiuMIGMDr","link":"https://vimeo.com/showcase/10659685/video/984173280","name":"Noah's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T22:40:45.286Z","Revenue Growth":2,"Risk Mitigation":1,"Industry Vertical":"Healthcare / Nutraceuticals","ready_for_display":false,"Talent Development":1,"Agility & Innovation":3,"Customer Acquisition":5,"Operational Efficiency":1,"Short Solution Description":"Evinature is a natural, plant-based health solution that significantly improved a child's severe eczema and allergies, enabling him to live a normal, symptom-free life."}},{"id":"rwugEvGJ04xOpYU1wCxTHymCgfa6JilNT9tV8ANNQtS8x9cuakbLMJ","link":"https://vimeo.com/showcase/10659685/video/966541603","name":"Josh's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T22:47:55.055Z","Revenue Growth":4,"Risk Mitigation":4,"Industry Vertical":"Healthcare / Nutraceuticals","ready_for_display":false,"Talent Development":1,"Agility & Innovation":4,"Customer Acquisition":4,"Operational Efficiency":1,"Short Solution Description":"Evinature provides evidence-based natural supplements, specifically curcumin and boswellia, for managing inflammatory bowel diseases (IBD) like Crohn's and Ulcerative Colitis, offering an alternative or complementary treatment option."}},{"id":"uAkmVYr0Jj5RjbVYGYpni4dTQRah4n6KcAutuQVwsN5y5z69ZGSAor","link":"https://vimeo.com/showcase/10659685/video/953839586","name":"Kirsten's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T22:56:47.140Z","Revenue Growth":3,"Risk Mitigation":1,"Industry Vertical":"Health & Wellness","ready_for_display":false,"Talent Development":1,"Agility & Innovation":3,"Customer Acquisition":5,"Operational Efficiency":1,"Short Solution Description":"Evinature offers natural, science-backed solutions for gut health, as highlighted by a customer's testimonial detailing a life-changing recovery from chronic IBS symptoms."}},{"id":"vOCBFgAgy2LcunwIcDvuFoTdkw5At9ICBgPADY92mbTd3RIWaEhHQB","link":"https://vimeo.com/showcase/10659685/video/944357986","name":"Keith's Evinature Story","ai_analysis":{"Confidence":0.95,"created_at":"2025-07-22T23:02:49.503Z","Revenue Growth":3,"Risk Mitigation":1,"Industry Vertical":"Health & Wellness / Nutraceuticals","ready_for_display":false,"Talent Development":1,"Agility & Innovation":3,"Customer Acquisition":5,"Operational Efficiency":1,"Short Solution Description":"Evinature offers natural health supplements and protocols, specifically for gut health conditions like SIBO and IBS, providing effective solutions that significantly improve customer well-being and quality of life."}},{"id":"y7pWfKi8jHYhvEzlntYkIr63cPPBuqnKaloWFugNQG8gZTWllQVZz2","link":"https://vimeo.com/showcase/10659685/video/924319843","name":"Tomer's Evinature Story","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T23:13:20.894Z","Revenue Growth":3,"Risk Mitigation":1,"Industry Vertical":"Natural Health & Wellness","ready_for_display":false,"Talent Development":1,"Agility & Innovation":3,"Customer Acquisition":5,"Operational Efficiency":1,"Short Solution Description":"Evinature offers natural health solutions, specifically for chronic digestive conditions like IBS and Crohn's disease, as demonstrated by a customer testimonial showcasing significant life improvement and product efficacy."}},{"id":"yHL0jeXkhJ9ZFsXjPsgF75sO0eXcunCqaUdAflF9fQtVTC6eIWmskd","link":"https://vimeo.com/showcase/10659685/video/928307514","name":"Almog and His Mother's Evinature Story","ai_analysis":{"Confidence":0.8,"created_at":"2025-07-22T23:13:41.883Z","Revenue Growth":4,"Risk Mitigation":4,"Industry Vertical":"Healthcare / Nutraceuticals","ready_for_display":false,"Talent Development":1,"Agility & Innovation":4,"Customer Acquisition":5,"Operational Efficiency":1,"Short Solution Description":"Evinature provides evidence-based natural dietary supplements for managing inflammatory bowel diseases (IBD) like Crohn's and Ulcerative Colitis, offering a scientifically validated alternative or complementary treatment to improve patient quality of life."}}],"businessmodels":["B2B","B2B2C","B2C"],"productstage":"Released","products":["QD1","Agile","CurQD®-1","CurQD®-2","CurQD®-3","CurQD® Protocol Red","CurQD® Protocol Orange","Cura","CurQD®-5","CurQD® Protocol Blue","Exhale","CurQD® Protocol Blue +","DivertX","CurQD® Protocol Green","CurQD® Protocol Yellow"],"geomarkets":["North America","Israel","Bahamas","Bosnia and Herzegovina","Poland","Hong Kong","South Africa","Western Europe","Australia","Turkey","Singapore","Honduras","Cyprus","Colombia","United Arab Emirates","New Zealand","South Korea","Romania"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":1,"lastfunding":"$2.5M","totalrounds":3,"fundingstage":"Seed","totalfunding":"$6.5M","publicinvestors":1,"lastpublicfunding":2500000,"totalpublicrounds":3,"totalpublicfunding":6500000},"team":[{"name":"Apan Amos Damri","email":"apan@evinature.com","phone":"","gender":"Male","userid":"vWHEPqDkJseOUeJkRnf5cl64ukqCnOlitVfFs37NxzXawMgKNyUm29","bounced":false,"claimed":null,"founder":1,"urlname":"apan-amos-damri-1","visible":1,"memberid":"7CuZu1zXUUsgK139QBxDZUY8d23pTNdvwOVRo21GAIXPWPzytTyl5S","position":"Founder, CEO","last_name":"Damri","claimtoken":"SxjoAQ1VQEGG7xI4pIwyE0OTRfm0j9ii5DbIRtF3Tztj1HFdNysEi9","first_name":"Apan Amos","picturekey":"$cD1Iii1PCUG23SuCzmhgSvq2n66YJIsQZSdTcdPn5IRVhUTxe2tCWi.jpeg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/apan-amos-damri-5387416/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-01-04 17:50:52.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$cD1Iii1PCUG23SuCzmhgSvq2n66YJIsQZSdTcdPn5IRVhUTxe2tCWi.jpeg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Dr. Prof. Shomron Ben-Horin M.D.","email":"shomron@evinature.com","phone":"","gender":"Male","userid":"PmWbwSjmwV17De3Ow8NaRDyLnfxszqogO5qFfXwgWhujpQX137aXqu","bounced":false,"claimed":null,"founder":1,"urlname":"shomron-ben-horin-md","visible":1,"memberid":"A5ZQOHhbAlEYaLb83BTCQVWkjCn2jBO7f2ROl3EbrKRjr7QvRB6mkt","position":"Founder, Chief Medical Officer","last_name":"Ben-Horin M.D.","claimtoken":"TX3Pc4NmOA6uKy7XOJr5kvofrPp16rQRlKLgj2dhenu9vUAUx2VjNJ","first_name":"Dr. Prof. Shomron","picturekey":"$stx9IeU7E6LOeZkYMo5lMARbhfcOV4bLB0GMjMdvO8gwT6rkTodqEV","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/shomron-ben-horin-m-d-0200a4a7/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2024-06-03 18:19:45.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$stx9IeU7E6LOeZkYMo5lMARbhfcOV4bLB0GMjMdvO8gwT6rkTodqEV","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Nir Salomon ChB","email":"nir@evinature.com","phone":"","gender":"Male","userid":"2ZxmEGZo6JJK1Fx3FvXpfD8Ciw1pl6UZeK4nSrHKf5d331fWXae7Vc","bounced":false,"claimed":1,"founder":1,"urlname":"nir-salomon","visible":1,"memberid":"wNnA0zXRvuwIlfMZo6DGA6tbEU8rk45OlT8Udqh4FD2aFs60d2V1Sq","position":"Founder, Head of R&D","last_name":"Salomon ChB","claimtoken":"ULcimE3ll7rHYltT7MJt4WLtqhtcgvoKRkYj39QohoVTxw8LNp8EkI","first_name":"Nir","picturekey":"$IdZSK7To0Mq1zHLjQGzgB84WJCMhjRCXex8FsDO5eRh19ONgGUC9wz.jpeg","claimeddate":"2022-12-05","linkedinurl":"https://www.linkedin.com/in/nir-salomon-448b89ba/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-12-05 13:05:53.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$IdZSK7To0Mq1zHLjQGzgB84WJCMhjRCXex8FsDO5eRh19ONgGUC9wz.jpeg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Shiri Mazor","email":"shiri@evinature.com","phone":"","gender":"Female","userid":"t6ETpkfIj8EfTeYsaBJCyljjOsSoxaaifYfs9lZpjRokajpbD7qDuR","bounced":false,"claimed":null,"founder":0,"urlname":"shiri-mazor","visible":1,"memberid":"s67tanXgNQdhfWTvrffK90lebfSm7QaVulijNiDyQpS1bo95RD8upi","position":"Chief Operations Officer","last_name":"Mazor","claimtoken":"KyXtb3enC8xcWtIEsaL38nAR5ggVj7RGqc7BOl9Bz4YYpirzk1Px8Y","first_name":"Shiri","picturekey":"$nGoG7ouLmFGverVIMPTdvkVnX6W7y4GvFh13xzzekNqWbSrthXr0Pv","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/shirimazor/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2024-01-04 17:51:13.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$nGoG7ouLmFGverVIMPTdvkVnX6W7y4GvFh13xzzekNqWbSrthXr0Pv","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Roi Ben Haim","email":"roi@evinature.com","phone":"","gender":"Male","userid":"M3lMYNRyf9yH8hKGQPqeCxAa8D51a73oW2derrhJxQFDPHCAoQQwqL","bounced":false,"claimed":null,"founder":0,"urlname":"roi-ben-haim","visible":1,"memberid":"pLp6aMsHCyi4zwsGVIfaav4KbP5QsSWJX3NnknWSo3Pa16ZnuRl4AD","position":"Chief Technology Officer","last_name":"Ben Haim","claimtoken":"4DsKteYKg5JOwfL2SVbJ6OjjJKtJTyWlZV7BoYe39KAQTyG9bpf1rh","first_name":"Roi","picturekey":"$LyXJUrGnvnX4j61cigi8hGGXUkYfghTwVmwMVAUMI3Bm1g4ZXvOJdO.jpeg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/roie-evinature-58b07a24b/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2024-06-03 18:19:31.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$LyXJUrGnvnX4j61cigi8hGGXUkYfghTwVmwMVAUMI3Bm1g4ZXvOJdO.jpeg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Ella Lorentz","email":"ella@evinature.com","phone":"","gender":"female","userid":"72TVX7bBrVUfQ0CK5VAxVnS9VMa1TVuGMMM3DkRGFCWBSO34ZG2939","bounced":false,"claimed":null,"founder":0,"urlname":"ella-lorentz","visible":1,"memberid":"Nnanyptbv2JfCB0bPz7xDc3jnRwoX8Ox7wsBrPBpAfA0PBZEmXCsHG","position":"Vice President of Operations","last_name":"Lorentz","claimtoken":"Dn23avXZtQGMDy3fyglov6almlbIGKstbKn6pfTOxH7eeCElvMOOv2","first_name":"Ella","picturekey":"$SGoXXyGUxcW3ZAaPuu79sC30umnJf6UocnbYqIxcTUWZ5PZboxa09B.webp","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/ella-lorentz-3275a2219/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2024-01-04 17:51:15.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$SGoXXyGUxcW3ZAaPuu79sC30umnJf6UocnbYqIxcTUWZ5PZboxa09B.webp","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Shirli Tehar Lev","email":"shirli@evinature.com","phone":"","gender":"Female","userid":"Ye2g3EFCQulogM4UkAU0hkgib46uCaxDE60kupEfde4fTJvlubw0sB","bounced":false,"claimed":null,"founder":0,"urlname":"shirli-tehar-lev","visible":1,"memberid":"mr4TNQDNVLNXNy23ZFFE7LMe7OvbwWX04hxTUSsxQ5tSXresRgNCCe","position":"Head of Customer Success","last_name":"Tehar Lev","claimtoken":null,"first_name":"Shirli","picturekey":"$j7qQ65koxqvDjdmA6Up85ZfFetSzVrb1psBSmYTZoWfLwxscuo7oJf.jpeg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/shirli-tehar-lev/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$j7qQ65koxqvDjdmA6Up85ZfFetSzVrb1psBSmYTZoWfLwxscuo7oJf.jpeg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Idan Glaser","email":"idan@evinature.com","phone":"","gender":"Male","userid":"JhsnoExILkmQOxbvowtUJCn9xYsdfWJdVTwiJxgRfrQk3FWtP58P9S","bounced":false,"claimed":null,"founder":0,"urlname":"idan-glaser","visible":1,"memberid":"EEn3RcxIaO4fRR03bUdsqC6DYfaF6lzMSFd69BEQsGlyWLsHKCBo34","position":" User Acquisition Manager","last_name":"Glaser","claimtoken":null,"first_name":"Idan","picturekey":"$8w6TQqwwADS1VtIEG5G1SnszPyRTJ2CBCnDErvVsLRTyVHqjWxJG1d.jpeg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/idan-glaser/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$8w6TQqwwADS1VtIEG5G1SnszPyRTJ2CBCnDErvVsLRTyVHqjWxJG1d.jpeg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Kathryn Johnston-Avrahami","email":"kathryn@evinature.com","phone":"","gender":"Female","userid":"cUHFl0TrytbkfxB4uNai33nUcCvBMG8xqHsxn2H4hAFBPdj4MaDQMb","bounced":true,"claimed":null,"founder":0,"urlname":"kathryn-johnston-avrahami","visible":1,"memberid":"5OEKgBPEzEY7ohqwoebnevxiKJ9R8MidJvh7aZVrJJpWRaPyX31Qbk","position":"Clinic Support","last_name":"Johnston-Avrahami","claimtoken":null,"first_name":"Kathryn","picturekey":"$9r7uEXf44QhZATf78ECX4ZJlhfJbfhXtNdYzXBZxsZ5KNu26bjQkQg.png","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/kathryn-avrahami/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$9r7uEXf44QhZATf78ECX4ZJlhfJbfhXtNdYzXBZxsZ5KNu26bjQkQg.png","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Emma Grill","email":"emma@evinature.com","phone":"","gender":"Female","userid":"2kvTZqbA062lFZ8ibsfgdlu9t5TGF4EY4aZ8A1jESsWLpkUxM9WBhR","bounced":false,"claimed":null,"founder":0,"urlname":"emma-grill","visible":1,"memberid":"62yUFwWJkb9lL447hbkbKi5n2KCITGXtcQ3sBGzpvvDQPQ9U2h4Wms","position":"Clinic Support","last_name":"Grill","claimtoken":"F4EpIrDxJFzm5GvzrjvIIrbvJ4Zw1lfVv92dFEUte1AaCNaE9AEcoU","first_name":"Emma","picturekey":"$VfEVjrGxMy1zWMzITx8YOgLI7qZuSSDio6SbYNCM9Vs1qkeL9MuiAx.jpeg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/emma-grill-85720a229/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2024-06-03 18:19:27.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$VfEVjrGxMy1zWMzITx8YOgLI7qZuSSDio6SbYNCM9Vs1qkeL9MuiAx.jpeg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Eliezra Oren","email":"eliezra@evinature.com ","phone":"","gender":"Female","userid":"b0EYH5eKEYDD0OQCMcSxBsmQAo3bWO9rmt52yOfIEYsypqLcJlMSuP","bounced":false,"claimed":null,"founder":0,"urlname":"eliezra-oren","visible":1,"memberid":"uo6fuhd2EkBAl1kN88NcL2oEBjgDcNXp2lXGTQeFDJaFSDIbmXpsDQ","position":"Clinic Support","last_name":"Oren","claimtoken":null,"first_name":"Eliezra","picturekey":"$ouNC1xrxUa6mwMT9De9PE3PY1bMd45nD8tDPcucz1gZmMAjQCuULO2.jpeg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/eliezra-o-4a0392196/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$ouNC1xrxUa6mwMT9De9PE3PY1bMd45nD8tDPcucz1gZmMAjQCuULO2.jpeg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Summer Pitocchelli","email":"","phone":"","gender":"Female","userid":"QrrnKWiXhHwLmS6H7pwHH363wIjuHFSKuwZotMrd4avNJetV60mtRG","bounced":false,"claimed":null,"founder":0,"urlname":"summer-pitocchelli","visible":1,"memberid":"vEZLe99ILgzdTpwYRe9R8P4aFh2zme42IkJ6voIpn1T7xSL02eipWw","position":"Content Writer","last_name":"Pitocchelli","claimtoken":null,"first_name":"Summer","picturekey":"$BmNmQJ3UZaHuT7E9UMVPLHAYTS7Po9Dp3ysBRBGKE4bLw61oYHcBPx.jpeg","claimeddate":null,"linkedinurl":null,"unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$BmNmQJ3UZaHuT7E9UMVPLHAYTS7Po9Dp3ysBRBGKE4bLw61oYHcBPx.jpeg","linkedin-display":"none","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Dr. Prof. David T. Rubin M.D.","email":"","phone":"","gender":"Male","userid":"urXp0L58RQZm3YoAX3wf90shg2rOIhZ0QezyiGztWoC0lTO5I7JP74","bounced":false,"claimed":null,"founder":0,"urlname":"david-rubin-3","visible":1,"memberid":"CTOgJSclaML84na1l245Tz7nhHYpbfF30qcyeEUMgk1OimqAnXr2VA","position":"Medical Advisor","last_name":"Rubin M.D.","claimtoken":null,"first_name":"Dr. Prof. David T.","picturekey":"$qiB0Smuj9jWk6nagBq6xnnS18BRdVI426prfk2hrSIqcbbpoxIqsuC.jpeg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/david-rubin-44b5386/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$qiB0Smuj9jWk6nagBq6xnnS18BRdVI426prfk2hrSIqcbbpoxIqsuC.jpeg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Rotem Sigall Boneh R.D.","email":"","phone":"","gender":"Female","userid":"UuTHDhU6OzJcX8YDIsQeLAf60RJon8ZUM1W7Ef4XETPlhsCsz1T7Zn","bounced":false,"claimed":null,"founder":0,"urlname":"rotem-sigall-boneh-rd","visible":1,"memberid":"a4D9Z2pnEWt2JVO4aFxYYJlCyVaRq1YUjxaL2PwG10moZyU8beHQwQ","position":"Medical Advisor","last_name":"Sigall Boneh R.D.","claimtoken":null,"first_name":"Rotem","picturekey":"$RvKvayjlM3okjZSJ6Ff37qW23TmoO59t6bdxP1weQ81WFbJT6F46VI.png","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/rotem-sigall-boneh/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$RvKvayjlM3okjZSJ6Ff37qW23TmoO59t6bdxP1weQ81WFbJT6F46VI.png","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"William D. Chey M.D.","email":"","phone":"","gender":"Male","userid":"gFJTrZ5fCaF9mdt97tIJ1dkizNAAjp98YmmuiKhvp1YsUaU0VZ6Uye","bounced":false,"claimed":null,"founder":0,"urlname":"william-d-chey-md-1","visible":1,"memberid":"xH2VTWbsQ5BTIRfeSVyY5QCTbbnCrngUV0U3RTcdzi4FB0EiTO5ueu","position":"Medical Advisor","last_name":"Chey M.D.","claimtoken":null,"first_name":"William D.","picturekey":"$IVPq873p2Mqi37Tb3n2YPSAD3VM0eSaTTYQSUKOQHpe0kZWL7bZZIM.jpeg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/william-d-chey-0310651a/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$IVPq873p2Mqi37Tb3n2YPSAD3VM0eSaTTYQSUKOQHpe0kZWL7bZZIM.jpeg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Dana Eden Shhori","email":"","phone":"","gender":"Female","userid":"BXKFCUfphXJNxT7Gif6EhUrBfdX6QTwxlQWA0JOKYvQElbKac7BdgU","bounced":false,"claimed":null,"founder":0,"urlname":"dana-eden-shhori","visible":1,"memberid":"DwyPj0Tk9ueLAAKTFeJngdOABg4Ak1wGVRXUrkqTdXH1HwrVq5J1j1","position":"Office Manager","last_name":"Eden Shhori","claimtoken":null,"first_name":"Dana","picturekey":"$1SR5EkFBxBtmszBalSGJvYQT7o2VuTdYofzJse9hR6LKZplD45k1Nu.png","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/dana-eden-shhori-854450213/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$1SR5EkFBxBtmszBalSGJvYQT7o2VuTdYofzJse9hR6LKZplD45k1Nu.png","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Ofri Raif Dali","email":"ofri@evinature.com","phone":"","gender":"Female","userid":"fO2EM5Ge6V0Azsj5g2zTtQYpFCs1xEQYPNtCuWZmxWWl0CKPyYXK3q","bounced":false,"claimed":null,"founder":0,"urlname":"ofri-raif-dali","visible":1,"memberid":"ZqNJ8tKj5H2EfuVsojH7OoqDELOEr1QPFwAD8EqEGJuFayvxn4q6Kj","position":"Product Manager","last_name":"Raif Dali","claimtoken":"U9aGQwgkBULY9pJXJusnGkV3T6yeSX6CaFJJ6qqZXN0XwkmtxDhEla","first_name":"Ofri","picturekey":"$djdK9sEoS7YTjuz8NYc7G5ZAdRvcEYvZRWRxyKwE26qmQZEj7JqL78.jpeg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/ofri-raif-dali-73a19966/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2024-06-03 18:19:02.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$djdK9sEoS7YTjuz8NYc7G5ZAdRvcEYvZRWRxyKwE26qmQZEj7JqL78.jpeg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Jonathan Schwartzman","email":"","phone":"","gender":"Male","userid":"aodV8VHE7KBhRcap9pSfubGM8XnHS0GCSCGjBukK0B5m5FBvctvBZR","bounced":false,"claimed":1,"founder":0,"urlname":"jonathan-schwartzman","visible":1,"memberid":"ctNeRs5gZl2ep65xdBFpLV4BL8hxccb0rbTzM19UFjuEP7rXGbJUJ2","position":"Senior Marketing Manager","last_name":"Schwartzman","claimtoken":null,"first_name":"Jonathan","picturekey":"$P7pkKEOIeViN2UiZc84xt6BD0G3l45AE8IkKjYxInyCi8WMYkjQoyh.jpeg","claimeddate":"2022-11-29","linkedinurl":"https://www.linkedin.com/in/jonathanschwartzman/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$P7pkKEOIeViN2UiZc84xt6BD0G3l45AE8IkKjYxInyCi8WMYkjQoyh.jpeg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":null,"tag_line_edited":null,"sector":"Digital Health and Medical Technologies","sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMGgoMMJDA","fullname":"Yanina Wainscheinker"},"biverifydate":null,"crunchbaseid":null,"lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Jonathan Schwartzman","creator_email":"jonathan@evinature.com","createdate":"2022-11-29T00:00:00.000Z","biverification":"Yanina Wainscheinker","sectorverification":null,"affiliatedOrganizations":null,"timeline":[{"id":"nAYHVKtNQ8NeK6RJMY6l2aDFO7yI09zQYBNvfgTTT940mZHmMKxrSU","date":"Feb 2024","amount":"$2.5M","source":"","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":2500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"fCFQGIXb7dAFPdvN1if5YMFpIH7FmbPYG5Jih9uQGruWDtkCC2VFhL","date":"Oct 2023","amount":"$2M","source":"","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":2000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"vY0WEejGge2ItoZqHjk1HUoIadgP2N7JhC1jXfdtvkeKum78ziHmxs","date":"Jun 2022","amount":"$2M","source":"rasham","eventtype":"FundingRoundEvent","investment":[{"name":"Ratio Technologies","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/ratio-technologies","logokey":"$PLkFcndUX7cwRrRHWDYYXwg29Smj1EvywzgeKw2pberGDg4jX1F8p7","tagline":null,"urlname":"/investor_page/ratio-technologies","isisraeli":1,"investorid":"67VpLYXRy2rnHNPzR0lqfo7bK1RsqfE66PASPHqUsjWM12qmoek23z","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"MynL5peSZjWAhnrZKVCarADQ1NydfAUeIwxBwEpQBDJkKgsOWM1OMn","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$PLkFcndUX7cwRrRHWDYYXwg29Smj1EvywzgeKw2pberGDg4jX1F8p7","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Pre-Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":2000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"4/2021","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Evinature","logourl":"https://storage.googleapis.com/clean-finder-353810/$vuM3IGluLfm2P2BtUqAnsuHR68exJCikQC1iAvxgv4quP77hhIqhmZ","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$vuM3IGluLfm2P2BtUqAnsuHR68exJCikQC1iAvxgv4quP77hhIqhmZ","seoabout":"Evinature was founded on the nexus of two medical philosophies. By bridging the gap between modern and traditional medicine, we’re able to provide more pat...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":18,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Herbals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQlIIIDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"}],"classificationDelimited":["IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA>Herbals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQlIIIDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA"],"classificationsViewModel":"|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|2:>TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA/Herbals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQlIIIDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drugs Discovery & Development","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drugs Discovery & Development"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Patients","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Patients"}]}]}],"coreTechnology":[{"title":"Biologicals","key":"0-0","path":"TechnologyClassificationModel>Biologicals","children":[{"title":"Herbals","key":"0-0-0","path":"TechnologyClassificationModel>Biologicals>Herbals"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Herbals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQlIIIDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Drugs Discovery & Development"],"coreTechnology":["Biologicals","Herbals"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Patients"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{}}